<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Medical care of the military veteran</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Medical care of the military veteran</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Medical care of the military veteran</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael J Roy, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jeremy G Perkins, COL, MD, FACP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark D Aronson, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sara Swenson, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jane Givens, MD, MSCE</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 31, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3796084"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The nature of war-related injuries has changed considerably over time. Preventive measures, ranging from improved infection control to protective gear, have been effective in reducing military morbidity and mortality [<a href="#rid1">1,2</a>]. In addition, the rapidity of evacuation and access to higher-quality care have markedly improved survival rates for battle injuries. Clinicians caring for the new generation of combat veterans need to be prepared for a different distribution of injuries compared with prior wars. As an example, it is more common to see survivors of traumatic brain injury (TBI) and amputees who have lost multiple limbs (as the torso is often spared by body armor). Moreover, there is evidence that those who have been previously injured in combat are at greater risk for the development of hypertension, coronary artery disease, diabetes mellitus, and chronic kidney disease [<a href="#rid3">3</a>].</p><p>Despite the evolution of war-related injuries over time, there are three aspects of injuries that have not changed for the returning veteran. First, while non-combat injuries (eg, infections, gastrointestinal illness, and musculoskeletal problems not related to battle) have decreased dramatically in more recent conflicts, they invariably outnumber combat-related injuries [<a href="#rid4">4</a>]. Second, the psychological effects of war are greater in number and duration than the physical effects over the long term. Third, complaints in veterans presenting for care after deployment tend to be similar in distribution and frequency to those in the general primary care population [<a href="#rid5">5</a>]. Although the overall medical care of the returning veteran may be similar to that of the general population, there are certain issues (eg, TBI, psychological sequelae, readjustment to society following deployment) that are of particular relevance to veterans.</p><p>This topic will provide an overview of medical conditions commonly encountered in returning veterans, with a particular emphasis on United States veterans. Specific medical conditions associated with combat are discussed in further detail elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/500.html" rel="external">"Posttraumatic stress disorder in adults: Epidemiology, pathophysiology, clinical features, assessment, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1721.html" rel="external">"Unipolar depression in adults: Assessment and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/496.html" rel="external">"Generalized anxiety disorder in adults: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4825.html" rel="external">"Traumatic brain injury: Epidemiology, classification, and pathophysiology"</a>.)</p><p></p><p class="headingAnchor" id="H3796170"><span class="h1">PHYSICAL INJURY DUE TO COMBAT</span><span class="headingEndMark"> — </span>The rate of combat-related fatalities has decreased over recent wars. This can be attributed to the use of tourniquets, modern body armor, rapid evacuation, early limb salvage, and improved hemostatic resuscitation practices [<a href="#rid2">2,6,7</a>]. Soldiers with combat injuries, which may have been fatal in previous conflicts, are arriving more rapidly to military treatment facilities in better physiologic condition and are able to receive higher levels of care.</p><p>There are clear differences between military and civilian trauma populations. Whereas blunt trauma, primarily due to motor vehicle accidents and falls, represents the most common injury among civilians in the United States, penetrating injuries are more common in combat casualties [<a href="#rid8">8</a>]. The most common causes of serious penetrating injuries in civilian trauma centers are stabbings and low-velocity gunshot wounds, whereas in the military they tend to be high-velocity gunshot wounds and high-energy explosive munitions including improvised explosive devices (IEDs), mortars, and rockets which can produce varied fragmentation, concussive blast, and thermal injuries [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H3796184"><span class="h2">Amputations</span><span class="headingEndMark"> — </span>A review of 8056 military casualties in Afghanistan and Iraq found that more than 70 percent were due to extremity injuries severe enough to either result in evacuation from combat or to prevent return to duty within 72 hours [<a href="#rid10">10</a>]. Some form of explosive device was involved with 88 percent of these injuries. Major injury resulted in amputations proximal to the wrist or ankle in 7.4 percent, compared with 8.3 percent in the Vietnam War, although service members are currently able to survive more serious injuries than in prior wars.</p><p>Amputee care and the quality of prostheses have improved dramatically as a result of efforts to provide combat amputees with maximum function and mobility. Amputees are able to remain on active duty in the military after injuries that they may not have survived in prior wars. Functional capacity assessment can be helpful in determining whether an amputee is able to return to their usual home and work environment [<a href="#rid11">11</a>]. This is usually performed in conjunction with physical and/or occupational therapy. (See  <a class="medical medical_review" href="/d/html/2791.html" rel="external">"Disability assessment and determination in the United States"</a>.)</p><p>Phantom limb pain is a common symptom following amputations [<a href="#rid12">12</a>]. This may require chronic pain management, including referral to a pain specialist. (See  <a class="medical medical_review" href="/d/html/16695.html" rel="external">"Lower extremity amputation", section on 'Phantom limb pain'</a> and  <a class="medical medical_review" href="/d/html/15224.html" rel="external">"Upper extremity amputation", section on 'Phantom limb pain'</a>.)</p><p class="headingAnchor" id="H3796191"><span class="h2">Traumatic brain injury</span><span class="headingEndMark"> — </span>Traumatic brain injury (TBI) is an important cause of disability among returning veterans. TBI encompasses a broad range of pathologic injuries to the brain of varying clinical severity that result from head trauma. (See  <a class="medical medical_review" href="/d/html/4825.html" rel="external">"Traumatic brain injury: Epidemiology, classification, and pathophysiology"</a>.)</p><p>While there is not complete agreement regarding classification, TBI may be best characterized by a combination of the Glasgow Coma Scale score  (<a class="graphic graphic_table graphicRef81854" href="/d/graphic/81854.html" rel="external">table 1</a>), duration of loss of consciousness, and clearly abnormal computed tomography (CT) or magnetic resonance imaging (MRI) of the brain. Based on these criteria, as many as 99 percent of service members diagnosed with TBI have mild TBI, including transient or no loss of consciousness [<a href="#rid13">13</a>]. Mild TBI is difficult to distinguish from other conditions [<a href="#rid14">14</a>], as symptoms of mild TBI (eg, concentration impairment, irritability, and headaches) overlap with symptoms of posttraumatic stress disorder (PTSD) and depression. Furthermore, veterans with TBI may be at higher risk for PTSD [<a href="#rid15">15</a>], and the combination of the two is associated with cognitive impairment [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/d/html/4828.html" rel="external">"Acute mild traumatic brain injury (concussion) in adults"</a>.)</p><p>TBI is a diagnosis given at the time of injury, based upon the circumstances of the inciting event, whereas persistent symptoms that may follow mild TBI are described as a postconcussion syndrome. The most common complaints of postconcussion syndrome include headache, dizziness, cognitive impairment, and psychological symptoms. Most patients recover quickly from postconcussion syndrome (within several weeks), although a minority have prolonged disability. A brain MRI should be performed to exclude other causes if there are persistent and disabling complaints. In the absence of a defined specific treatment for postconcussion syndrome, symptomatic treatment should be offered, which may include migraine medications, analgesics, psychological counseling, and/or psychotropic medications. (See  <a class="medical medical_review" href="/d/html/4830.html" rel="external">"Postconcussion syndrome"</a>.)</p><p>Moderate to severe TBI represents only a small fraction of those returning from the wars. Moderate-to-severe TBI usually requires aggressive management and may lead to long-term disability and cognitive dysfunction. A multicenter prospective double-blind, randomized, placebo-controlled trial identified that the N-methyl-d-aspartate antagonist <a class="drug drug_general" data-topicid="8508" href="/d/drug information/8508.html" rel="external">amantadine</a> produced more rapid recovery of neurologic function during the four-week treatment period [<a href="#rid17">17</a>]. However, the placebo group did show improvement during an ensuing two-week follow-up period, so that the two groups had similar functional status after six weeks. (See  <a class="medical medical_review" href="/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury"</a>.)</p><p class="headingAnchor" id="H617393371"><span class="h2">Other</span><span class="headingEndMark"> — </span>Spinal cord, penetrating abdominal, and chest injuries are less common than in prior wars, likely due to body armor protecting the trunk and back [<a href="#rid18">18</a>]. Limb and head trauma are the most common types of injuries seen, with ocular trauma also occurring at a higher rate than in previous conflicts [<a href="#rid19">19</a>]. (See  <a class="medical medical_review" href="/d/html/4839.html" rel="external">"Chronic complications of spinal cord injury and disease"</a> and <a class="local">'Amputations'</a> above and <a class="local">'Traumatic brain injury'</a> above.)</p><p class="headingAnchor" id="H3796198"><span class="h1">PSYCHOLOGICAL SEQUELAE</span><span class="headingEndMark"> — </span>Potential psychologic sequelae are an essential consideration in the medical care of the returning veteran.</p><p class="headingAnchor" id="H3501606036"><span class="h2">Screening for psychological sequelae</span><span class="headingEndMark"> — </span>Screening for posttraumatic stress disorder (PTSD)  (<a class="graphic graphic_table graphicRef105765" href="/d/graphic/105765.html" rel="external">table 2</a>), depression  (<a class="graphic graphic_table graphicRef59307" href="/d/graphic/59307.html" rel="external">table 3</a>), anxiety disorders  (<a class="graphic graphic_table graphicRef77755" href="/d/graphic/77755.html" rel="external">table 4</a>), and alcohol and substance use disorders is important upon return from deployment (see  <a class="medical medical_review" href="/d/html/14843.html" rel="external">"Screening for unhealthy use of alcohol and other drugs in primary care"</a>). However, an initial screening will miss most cases of mental health problems, and repeated screening is necessary, especially between 3 and 12 months after return [<a href="#rid20">20,21</a>].</p><p>The effectiveness of screening is unclear. In the only randomized controlled trial to address this issue, postdeployment screening of United Kingdom veterans of the Afghanistan War for PTSD, depression or anxiety, and alcohol misuse was not effective in reducing the prevalence of these disorders 10 to 24 months later or in increasing the frequency of help-seeking [<a href="#rid22">22</a>]. These results may not be generalizable, however, as the screening assessment in this study was done by computer, which may be less effective than a face-to-face interview.</p><p>Of veterans who screen positive for a mental health disorder, less than half seek mental health care [<a href="#rid23">23</a>]. There is no evidence to suggest that most available treatments for PTSD, depression, and anxiety disorders are more or less effective in military service members than in civilians. Multidisciplinary suicide prevention programs designed for injured returning veterans may reduce the number of suicides related to combat-related injury [<a href="#rid24">24,25</a>]. The psychological sequelae of combat are important by themselves but are also associated with increased rates of cardiovascular risk factors such as obesity, dyslipidemia, tobacco use, and hypertension [<a href="#rid26">26,27</a>].</p><p class="headingAnchor" id="H341622647"><span class="h2">Posttraumatic stress disorder</span><span class="headingEndMark"> — </span>PTSD is characterized by intrusive thoughts, nightmares, and flashbacks of past traumatic events, avoidance of reminders of trauma, hypervigilance, and sleep disturbance. As war is outside the realm of normal human experience, battle experiences nearly always fulfill the first criterion for the definition of PTSD (exposure to a severe, traumatic event). The clinical manifestations and diagnostic criteria for PTSD are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/500.html" rel="external">"Posttraumatic stress disorder in adults: Epidemiology, pathophysiology, clinical features, assessment, and diagnosis", section on 'Clinical manifestations'</a>.)</p><p>The prevalence of PTSD and other mental health disorders varies based on the particular war, the veteran population being studied (eg, sex, branch of military), and when PTSD assessment is being performed (soon after return compared with years later). In a cohort study of 289,328 United States veterans of the Iraq and Afghanistan Wars who received health care through the Veterans Administration (VA) between 2002 and 2008, the overall prevalence of newly diagnosed PTSD was 21.8 percent, with the rate increasing over time [<a href="#rid28">28</a>]. PTSD and other psychological sequelae are being identified at higher rates than has historically been the case, and they are frequently not fully manifest until months or years after return [<a href="#rid20">20,29,30</a>]. (See  <a class="medical medical_review" href="/d/html/500.html" rel="external">"Posttraumatic stress disorder in adults: Epidemiology, pathophysiology, clinical features, assessment, and diagnosis", section on 'Combat'</a>.)</p><p>The PTSD checklist (PCL5) may be helpful in screening patients for PTSD and monitoring the progress of treatment over time [<a href="#rid31">31</a>]. The PCL5  (<a class="graphic graphic_table graphicRef105765" href="/d/graphic/105765.html" rel="external">table 2</a>) was developed based on the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria [<a href="#rid32">32</a>]. It features 20 questions, with each item scored from 0 to 4, with a total score range from 0 to 80. Scoring and indications for diagnostic evaluation are discussed separately. (See  <a class="medical medical_review" href="/d/html/500.html" rel="external">"Posttraumatic stress disorder in adults: Epidemiology, pathophysiology, clinical features, assessment, and diagnosis", section on 'Diagnosis'</a>.)</p><p>Veterans who screen positive for PTSD should be asked about suicidal ideation and intent. (See <a class="local">'Suicide'</a> below.)</p><p>Pharmacotherapy (eg, selective serotonin reuptake inhibitors [SSRIs]) and trauma-focused cognitive behavioral therapy are effective for patients with PTSD. However, PTSD in combat veterans may be more resistant to both pharmacologic and nonpharmacologic approaches than non-combat PTSD. Thus, combination therapy and/or a longer duration of therapy may be warranted. Pharmacotherapy and psychotherapy for PTSD are discussed separately. (See  <a class="medical medical_review" href="/d/html/117909.html" rel="external">"Posttraumatic stress disorder in adults: Treatment overview"</a> and  <a class="medical medical_review" href="/d/html/14634.html" rel="external">"Posttraumatic stress disorder in adults: Psychotherapy and psychosocial interventions"</a>.)</p><p class="headingAnchor" id="H341622527"><span class="h2">Depression</span><span class="headingEndMark"> — </span>Depression and anxiety disorders are also significantly associated with war and combat [<a href="#rid23">23,33,34</a>]. In a cohort study of 289,328 United States veterans of the Iraq and Afghanistan Wars who received health care through the VA between 2002 and 2008, the overall prevalence of newly diagnosed depression was 17 percent, with the rate increasing over time [<a href="#rid28">28</a>]. The clinical manifestations of depression are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/1721.html" rel="external">"Unipolar depression in adults: Assessment and diagnosis"</a>.)</p><p>The nine-item Patient Health Questionnaire (PHQ-9) has been the most studied and widely used screening tool for detection of depression. It is brief and easy to use. It consists of nine items that correspond to the nine DSM-5 criteria for unipolar major depression and one additional item assessing psychosocial impairment  (<a class="graphic graphic_table graphicRef59307" href="/d/graphic/59307.html" rel="external">table 3</a>). (See  <a class="medical medical_review" href="/d/html/83887.html" rel="external">"Screening for depression in adults", section on 'Patient Health Questionnaire-9'</a>.)</p><p>Veterans who screen positive for depression should be asked about suicidal ideation and intent. (See <a class="local">'Suicide'</a> below.)</p><p>Major depression is a treatable illness that responds to a variety of therapeutic interventions, including psychotherapy and pharmacotherapy. Other modalities (eg, electroconvulsive therapy, deep brain stimulation) may be needed in patients who do not respond to initial therapies. (See  <a class="medical medical_review" href="/d/html/1725.html" rel="external">"Unipolar major depression in adults: Choosing initial treatment"</a> and  <a class="medical medical_review" href="/d/html/14685.html" rel="external">"Unipolar depression in adults: Choosing treatment for resistant depression"</a>.)</p><p class="headingAnchor" id="H341622519"><span class="h2">Generalized anxiety disorder</span><span class="headingEndMark"> — </span>Generalized anxiety disorder (GAD) is characterized by excessive worry that is difficult to control and causes significant distress and impairment. Anxiety disorders are associated with an increased risk for multiple medical conditions, including myocardial infarction, among veterans [<a href="#rid35">35</a>]. Anxiety is often accompanied by other mental health problems among veterans, including depression, panic disorder, and substance use disorder [<a href="#rid36">36</a>]. A diagnostic algorithm to help distinguish GAD from major depression and other disorders can be found in the figure  (<a class="graphic graphic_algorithm graphicRef63149" href="/d/graphic/63149.html" rel="external">algorithm 1</a>). (See  <a class="medical medical_review" href="/d/html/496.html" rel="external">"Generalized anxiety disorder in adults: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis"</a>.)</p><p>A seven-item anxiety questionnaire (GAD-7) has been developed and validated in a primary care setting to help detect GAD  (<a class="graphic graphic_table graphicRef77755" href="/d/graphic/77755.html" rel="external">table 4</a>). (See <a class="local">'Depression'</a> above and  <a class="medical medical_review" href="/d/html/496.html" rel="external">"Generalized anxiety disorder in adults: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis"</a>.)</p><p>Veterans who screen positive for GAD should be asked about suicidal ideation and intent. (See <a class="local">'Suicide'</a> below.)</p><p>Both pharmacotherapy and cognitive behavioral therapy are efficacious as first-line treatment for generalized anxiety disorder. (See  <a class="medical medical_review" href="/d/html/101879.html" rel="external">"Generalized anxiety disorder in adults: Management"</a>.)</p><p class="headingAnchor" id="H4770042"><span class="h2">Suicide</span><span class="headingEndMark"> — </span>Veterans have a 21 percent higher suicide rate compared with the nonveteran population [<a href="#rid37">37</a>]. While high suicide rates among active-duty United States military personnel were reported in the early years of the wars in Afghanistan and Iraq [<a href="#rid38">38</a>], later studies found that rates are comparable to those of the general population, although those of reservists are slightly higher [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H260710777"><span class="h3">Incidence and risk factors</span><span class="headingEndMark"> — </span>Overall suicide rates among veterans in the United States are higher than among nonveterans (30 versus 24 per 100,000) and have increased since the early 2000s [<a href="#rid37">37</a>]. A study found that in 2016, the suicide rate among both male and female veterans was higher than in nonveterans (32 versus 27 per 100,000, and 14 versus 8 per 100,000 respectively) [<a href="#rid37">37</a>]. Among those at highest risk for suicide are soldiers discharged from inpatient psychiatric hospitalizations within the previous 12 months [<a href="#rid40">40</a>]. In other studies, additional risk factors for suicide include male sex, White race, recent demotion, depression, bipolar disorder, alcohol-related problems, sexual-minority status, traumatic brain injury (TBI), dishonorable discharge, and early military separation (separation from the military with &lt;4 years of military service) [<a href="#rid41">41-45</a>].</p><p>Deployment factors may also be associated with suicide [<a href="#rid44">44,46</a>]. A study of regular United States Army soldiers active between 2004 and 2009 found that suicide rates were higher in enlisted soldiers deployed either in their first year of service or with less-than-expected junior enlisted rank [<a href="#rid46">46</a>]. Suicide rates were also higher among females than males during deployment, and marriage had a protective effect only during deployment.</p><p class="headingAnchor" id="H260710813"><span class="h3">Assessment and referral</span><span class="headingEndMark"> — </span>Identifying PTSD, depression, anxiety, and alcohol and substance use disorder is an important first step in assessing for suicide risk [<a href="#rid47">47</a>]. (See <a class="local">'Screening for psychological sequelae'</a> above and  <a class="medical medical_review" href="/d/html/14843.html" rel="external">"Screening for unhealthy use of alcohol and other drugs in primary care"</a>.)</p><p>Veterans who screen positive for PTSD, depression, an anxiety disorder, or alcohol or substance use disorder should also be asked about suicidal ideation and intent, and, if present, the lethality of the plan should be evaluated [<a href="#rid48">48</a>]. Asking about suicidal ideation is discussed separately. (See  <a class="medical medical_review" href="/d/html/1708.html" rel="external">"Suicidal ideation and behavior in adults", section on 'Suicidal ideation and behavior'</a>.)</p><p>Veterans determined to be at imminent risk for suicide require immediate psychiatric services and must be monitored continuously until they are no longer an immediate suicide risk. After immediate safety has been ensured, underlying factors of psychiatric disorders, precipitating events, and ongoing life circumstances should be addressed with medications, counseling, and involvement of friends, family, and religious/community groups as appropriate [<a href="#rid49">49</a>]. (See  <a class="medical medical_review" href="/d/html/1708.html" rel="external">"Suicidal ideation and behavior in adults", section on 'Management'</a>.)</p><p>Veterans may be less inclined than civilians to seek help from mental health professionals. Service members may be reluctant to be identified with a mental health disorder because of potential career implications, and confidentiality must be assured [<a href="#rid50">50</a>]. In a case-control study, only 30 percent of veterans who had a history of depression and died by suicide had documentation that they were asked about suicidal ideation at their last visit [<a href="#rid51">51</a>]. Some of those visits occurred within seven days of the suicide. Among the veterans who were asked and subsequently committed suicide, 85 percent denied having suicidal ideation. The reasons for these denials are unclear but pose a challenge to the clinician.</p><p>Possible ways to improve suicide risk detection include: removing stigma to seeking help for depression or PTSD, enhancing understanding of mental health issues, recognizing warning signs, and social outreach, including reintegration of the veteran into society [<a href="#rid24">24</a>]. Although these programs appear to be helpful in suicide prevention, it is not clear which prevention initiatives are most effective for veterans given the absence of comparative data [<a href="#rid52">52</a>].</p><p>The Department of Defense, the VA, and other organizations in the United States have established several programs to prevent suicide in military service members [<a href="#rid53">53</a>], including clinical practice guidelines for assessing and managing those at risk for suicide [<a href="#rid54">54</a>]. Multidisciplinary suicide prevention programs designed for injured returning veterans may reduce the number of suicides related to combat-related injury [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H3796205"><span class="h2">Psychological complications of amputation</span><span class="headingEndMark"> — </span>Amputation increases the risk of psychological sequelae, above and beyond the risk simply associated with having been in a warzone [<a href="#rid55">55</a>]. Loss of a limb can profoundly influence one's self-image. One study found high rates of depression and anxiety up to two years post-amputation, which appear to decline thereafter to rates of the general population [<a href="#rid56">56</a>].</p><p>Concerns about independence and physical prowess may be more important than bodily image in military service members and veterans. Technological advances in prosthetics and rehabilitation enable a greater approximation to prior functional status and psychological recovery. There is limited literature addressing treatment of psychological factors associated with limb amputation. Based on evidence that more adaptive coping styles are associated with improved psychosocial adjustment and well-being, cognitive behavioral therapy should be incorporated into the management plan for veteran amputees [<a href="#rid21">21,57</a>].</p><p class="headingAnchor" id="H3796212"><span class="h2">Psychological complications of traumatic brain injury</span><span class="headingEndMark"> — </span>The relationship between TBI and psychological sequelae is complex. At least one-quarter to one-half of those with a history of TBI have major depression [<a href="#rid58">58-61</a>]. The overwhelming majority of those who experience a TBI during deployment to Afghanistan or Iraq are categorized as mild TBI, and there is a significant association between mild TBI and psychiatric symptoms [<a href="#rid62">62,63</a>]. One study found that more than 40 percent of those who had loss of consciousness met criteria for PTSD [<a href="#rid62">62</a>]. In this study, high rates of physical symptoms reported by soldiers could be attributed to PTSD and depression; when these conditions were accounted for in the analyses, there was no direct relationship between mild TBI and physical health problems (with the exception of headaches). Another study found that more than half of those in the VA system with a TBI diagnosis also had PTSD [<a href="#rid64">64</a>]. In a mail survey of 2235 United States military personnel returning from Afghanistan and Iraq, the PTSD score was more closely associated with residual TBI symptoms than any other factor [<a href="#rid62">62</a>].</p><p class="headingAnchor" id="H45326013"><span class="h1">CHRONIC MULTISYMPTOM ILLNESS</span><span class="headingEndMark"> — </span>Chronic multisymptom illness (CMI) is a term used to describe a condition in veterans from the Gulf War [<a href="#rid65">65</a>]. Veterans have symptoms such as fatigue, muscle and joint pain, and neurocognitive dysfunction that are not readily attributable to any disease. Parallels have been drawn between CMI and other postwar syndromes (eg, soldier's heart after the Civil War, effort syndrome in World War I, and acute combat stress reaction after the Korean Conflict) [<a href="#rid65">65</a>] (see  <a class="medical medical_review" href="/d/html/14621.html" rel="external">"Combat and operational stress reaction", section on 'Definition'</a>). CMI has not been linked with any particular etiology.</p><p>Estimates of the number of Gulf War veterans who suffer from CMI range from 175,000 to 250,000 [<a href="#rid66">66</a>]. CMI-related diagnoses, including chronic fatigue, fibromyalgia, and irritable bowel syndrome are increasingly recognized in veterans of the Iraq and Afghanistan conflicts [<a href="#rid67">67,68</a>].</p><p>There is little evidence to support particular therapies. However, treatments include the serotonin reuptake inhibitors, cognitive behavioral therapy, and mindfulness-based stress therapy [<a href="#rid66">66,69</a>]. (See  <a class="medical medical_review" href="/d/html/14634.html" rel="external">"Posttraumatic stress disorder in adults: Psychotherapy and psychosocial interventions", section on 'Introduction'</a>.)</p><p class="headingAnchor" id="H2154256"><span class="h1">CHRONIC PAIN</span><span class="headingEndMark"> — </span>The most common reason for recently deployed veterans to seek medical care is chronic pain associated with musculoskeletal injuries or traumatic brain injury (TBI) [<a href="#rid63">63</a>]. Arthritis is common among veterans; one survey found that 25 percent of veterans reported a diagnosis of arthritis [<a href="#rid70">70</a>].</p><p>Multidisciplinary care, involving physical therapy and mental health treatments such as cognitive behavioral therapy or biofeedback techniques, has been successful for the treatment of chronic pain [<a href="#rid71">71,72</a>]. Complementary medicine approaches such as acupuncture, yoga, relaxation training, and meditation may be used as adjunctive therapy. Chronic pain is associated with sleep disruptions, and nonpharmacologic interventions to improve sleep should also be considered [<a href="#rid73">73</a>]. (See  <a class="medical medical_review" href="/d/html/97867.html" rel="external">"Overview of the treatment of insomnia in adults"</a>.)</p><p>Though opioids are frequently prescribed for chronic pain, they should be prescribed with caution, if at all. For example, a study conducted in the Veterans Health Administration found that one-half of the patients with chronic non-cancer pain received opioids [<a href="#rid74">74</a>]. The median daily dose was 21 mg <a class="drug drug_general" data-topicid="9788" href="/d/drug information/9788.html" rel="external">morphine</a> equivalents, though 4.5 percent of patients receiving opioids had a mean daily dose &gt;120 mg morphine equivalents. Increased risk of overdose has been associated with daily morphine equivalent doses ≥100 mg, a history of opioid dependence, and hospitalization for a toxicity or overdose event in the previous six months [<a href="#rid75">75</a>]. PTSD and other psychiatric conditions are frequently comorbid and are associated with significantly greater rates of high-risk opiate use and consequent adverse events [<a href="#rid76">76-78</a>]. (See  <a class="medical medical_review" href="/d/html/126111.html" rel="external">"Approach to the management of chronic non-cancer pain in adults"</a>.)</p><p class="headingAnchor" id="H283153424"><span class="h1">SUBSTANCE USE DISORDER</span><span class="headingEndMark"> — </span>The stress of war leads to adverse health behaviors for some military service members. One anonymous self-report survey of more than 28,000 United States military personnel found that cigarette smoking was the most common adverse behavior (31.7 percent), followed by heavy alcohol use (21.0 percent) [<a href="#rid79">79</a>]. Illicit drug use excluding prescription drug misuse was reported in 5.2 percent. The rate has declined sharply since 1980, associated with random drug testing and strict intolerance of drug use within military ranks. Although differences in methodology make direct comparisons difficult, rates within the military appear to be no higher than in the general population. However, prescriptions for psychotropic medications, and abuse of prescription medications, have increased markedly in the general population in recent years, and this trend seems to be even more pronounced in the military in association with drawn-out conflicts in Iraq and Afghanistan [<a href="#rid79">79-81</a>]. In another study using data from the Veterans Administration (VA) health care system for veterans of Iraq and Afghanistan seen for an initial visit between 2001 and 2009, alcohol use disorder was diagnosed in 10 percent, drug use disorder in 5 percent, and both diagnoses in 3 percent [<a href="#rid82">82</a>]. Over 55 percent of veterans diagnosed with substance use disorder were also diagnosed with either posttraumatic stress disorder (PTSD) or depression and were 3.0 to 4.5 times more likely to have PTSD or depression than veterans without substance use disorder. Additionally, veterans with mental health diagnoses (and PTSD in particular) were more likely to have chronic pain requiring opioid treatment and were more likely to abuse prescription opioids with adverse health consequences [<a href="#rid77">77</a>]. A 2018 survey of a nationally representative population of United States military veterans found that 20.3 percent of those with alcohol use disorder met criteria for comorbid PTSD, while 16.8 percent with PTSD met criteria for alcohol use disorder; those with both conditions were more likely to also have depression, generalized anxiety disorder, suicidal ideation, and suicide attempts [<a href="#rid83">83</a>]. It is important to recognize that an element of selection bias occurs, with healthier individuals who are less likely to engage in illicit drug use tending to remain in active military service at higher rates. Conversely, for those who leave the military, only about one-quarter receive care in the VA system, and they tend to be disproportionately lower-income with more complex health problems [<a href="#rid84">84,85</a>].</p><p>The frequency and intensity of tobacco use increases in military populations after deployment [<a href="#rid79">79</a>]. Smoking rates are particularly high in those with combat-related PTSD. Tobacco cessation efforts that are integrated with PTSD treatment have been found to be more effective than referral to standard smoking cessation programs [<a href="#rid86">86,87</a>]. In advocating for smoking cessation in the veteran population, any concomitant psychological sequelae should also be addressed. (See  <a class="medical medical_review" href="/d/html/16634.html" rel="external">"Overview of smoking cessation management in adults"</a>.)</p><p>Although rates of alcohol or substance use disorder are comparable in military service members and their civilian counterparts, alcohol misuse (including drinking and driving, and being late for or missing work due to a hangover) seems to be more common after deployment, with 27 percent of veterans reporting this [<a href="#rid88">88</a>]. Alcohol misuse is associated with combat exposures involving threat of death or injury, as well as current functional impairment [<a href="#rid89">89</a>]. Thus, combat veterans returning from deployment should be screened for alcohol misuse. Their use of prescription and non-prescription medications should be carefully reviewed, with attention to unauthorized or illicit drug use as well. (See  <a class="medical medical_review" href="/d/html/14843.html" rel="external">"Screening for unhealthy use of alcohol and other drugs in primary care"</a>.)</p><p>Veterans who screen positive for alcohol or substance use disorder should be asked about suicidal ideation and intent. (See <a class="local">'Suicide'</a> above.)</p><p class="headingAnchor" id="H697646510"><span class="h1">MILITARY SEXUAL TRAUMA</span><span class="headingEndMark"> — </span>Military sexual trauma (MST) is defined as "sexual harassment that is threatening in character or physical assault that is sexual in nature that occurred while the victim was in the military" [<a href="#rid90">90</a>]. The prevalence of MST varies depending upon the definition used. A meta-analysis of 69 studies identified that 1.9 percent of males and 23.6 percent of females reported MST when the definition was limited to assault, whereas when it also included harassment, the rates rose to 3.9 percent of males and 38.4 percent of females [<a href="#rid91">91</a>]. Compared with other types of trauma (eg, combat trauma, illnesses, accidents, traumatic deaths), MST in female veterans is associated with a higher risk of developing posttraumatic stress disorder (PTSD), depression, and suicidal ideation [<a href="#rid92">92</a>]. (See <a class="local">'Posttraumatic stress disorder'</a> above.)</p><p class="headingAnchor" id="H4770835"><span class="h1">INFECTIOUS DISEASES</span><span class="headingEndMark"> — </span>Veterans are at risk for a wide range of infectious diseases depending upon the particular area of deployment. Risk may be decreased by the use of protective measures, such as special clothing, insect repellant, and prophylactic medications.</p><p class="headingAnchor" id="H4770842"><span class="h2">Malaria</span><span class="headingEndMark"> — </span><em>Plasmodium vivax</em> and <em>Plasmodium falciparum</em> are endemic in Afghanistan [<a href="#rid93">93</a>]. All soldiers from the United States deployed to Afghanistan are treated with chemoprophylaxis (mostly with <a class="drug drug_general" data-topicid="9393" href="/d/drug information/9393.html" rel="external">doxycycline</a>) [<a href="#rid94">94</a>] and soldiers deploying to high-risk areas receive <a class="drug drug_general" data-topicid="9810" href="/d/drug information/9810.html" rel="external">primaquine</a> terminal prophylaxis upon return. <em>P. falciparum</em> is generally apparent within two weeks of exposure and thus does not have a late presentation following return from deployment. However, <em>P. vivax</em> can present with late-onset or relapsing disease many months after initial infection and should be considered in the differential diagnosis of any veteran with fevers returning from Afghanistan. (See  <a class="medical medical_review" href="/d/html/5709.html" rel="external">"Malaria: Clinical manifestations and diagnosis in nonpregnant adults and children"</a> and  <a class="medical medical_review" href="/d/html/5706.html" rel="external">"Non-falciparum malaria: P. vivax, P. ovale, and P. malariae"</a>.)</p><p class="headingAnchor" id="H4770849"><span class="h2">Tuberculosis</span><span class="headingEndMark"> — </span>Tuberculosis (TB) is endemic in Afghanistan and Iraq. The United States military screens soldiers at high risk of exposure for TB prior to deployment using the purified protein derivative of tuberculin (PPD) and within 10 weeks of return from deployment. Deployment-associated conversion rates are approximately 2.5 percent in soldiers returning from Afghanistan and Iraq [<a href="#rid95">95</a>]. Soldiers identified with latent or active TB infection should receive appropriate treatment. However, it is conceivable that returning veterans, especially in the Reserve or National Guard, could bypass screening processes in place by the military. Providers should inquire as to the PPD status of returning veterans and should screen for TB if status is unknown. (See  <a class="medical medical_review" href="/d/html/8017.html" rel="external">"Treatment of tuberculosis infection (latent tuberculosis) in nonpregnant adults without HIV infection"</a> and  <a class="medical medical_review" href="/d/html/8015.html" rel="external">"Treatment of drug-susceptible pulmonary tuberculosis in nonpregnant adults without HIV infection"</a> and  <a class="medical medical_review" href="/d/html/115049.html" rel="external">"Tuberculosis infection (latent tuberculosis) in adults: Approach to diagnosis (screening)"</a>.)</p><p class="headingAnchor" id="H73400661"><span class="h2">Wound infections</span><span class="headingEndMark"> — </span>Wounds sustained in battle are frequently infected [<a href="#rid96">96</a>]. Lower-extremity wounds are likely to be due to improvised explosive devices (IEDs) or land mines and are at high risk of infection. Antibiotic therapy should be tailored to cultures due to the propensity of <em>Acinetobacter</em> and other Gram-negative organisms (eg, <em>Enterobacter</em>, <em>Pseudomonas</em>) to cause wound infections, as well as antibiotic-resistant organisms [<a href="#rid97">97,98</a>]. In addition, invasive fungal infections, including mucormycosis, have been reported in United States military personnel who sustained blast injuries during combat in Afghanistan [<a href="#rid99">99</a>]. (See  <a class="medical medical_review" href="/d/html/15079.html" rel="external">"Clinical assessment of chronic wounds"</a> and  <a class="medical medical_review" href="/d/html/2465.html" rel="external">"Mucormycosis (zygomycosis)"</a> and  <a class="medical medical_review" href="/d/html/2465.html" rel="external">"Mucormycosis (zygomycosis)", section on 'Combat-associated'</a>.)</p><p class="headingAnchor" id="H73400668"><span class="h3">Antibiotic-resistant bacteria</span><span class="headingEndMark"> — </span>Since the beginning of United States operations in Afghanistan and Iraq, there has been a notable increase in the number of wounded veterans with colonization or infection with antibiotic-resistant organisms [<a href="#rid100">100,101</a>]. Common organisms include methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) and extended-spectrum beta-lactamase (ESBL)–producing Gram-negative organisms (particularly <em>Escherichia coli</em>, <em>Klebsiella pneumonia</em>, <em>Pseudomonas aeruginosa</em>, and <em>Acinetobacter baumannii</em>) [<a href="#rid97">97,102,103</a>]. (See  <a class="medical medical_review" href="/d/html/3157.html" rel="external">"Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Epidemiology"</a> and  <a class="medical medical_review" href="/d/html/469.html" rel="external">"Extended-spectrum beta-lactamases"</a>.)</p><p>Wounded soldiers arriving to military medical treatment facilities are screened for colonization upon arrival. The colonization status of returning veterans may not be known to providers outside of military treatment facilities. Providers caring for returning veterans should be aware of possible colonization/infection with resistant organisms and should take this into account when considering antibiotic selection and implementing infection control practices. (See  <a class="medical medical_review" href="/d/html/4042.html" rel="external">"Infection prevention: Precautions for preventing transmission of infection"</a>.)</p><p class="headingAnchor" id="H4770856"><span class="h2">Cutaneous leishmaniasis</span><span class="headingEndMark"> — </span>Cutaneous leishmaniasis is a recognized parasitic infection in soldiers returning from Afghanistan and Iraq and presents as chronic, painless ulcerations on areas of skin exposure, most commonly the arms and legs [<a href="#rid104">104</a>]. While lesions from cutaneous leishmaniasis can present within 7 to 10 days of exposure, patients often do not seek medical care until they become chronic (assuming ulcers will heal spontaneously). Thus, cutaneous leishmaniasis typically presents in a window from 6 to 12 months after exposure and should be considered in the differential of painless ulcerations in veterans returning from Afghanistan and Iraq. (See  <a class="medical medical_review" href="/d/html/5689.html" rel="external">"Cutaneous leishmaniasis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/3895.html" rel="external">"Skin lesions in the returning traveler"</a>.)</p><p class="headingAnchor" id="H4770863"><span class="h2">Visceral leishmaniasis</span><span class="headingEndMark"> — </span>There are case reports of visceral leishmaniasis occurring in soldiers returning from Afghanistan and Iraq [<a href="#rid105">105</a>]. Clinical features include chronic fever, weight loss, fatigue, abdominal discomfort that may localize to the left upper quadrant, and hepatosplenomegaly. Laboratory abnormalities include anemia, leukopenia, and elevated liver-associated enzymes. Highly sensitive and specific serology-based enzyme-linked immunosorbent assay (ELISA) testing utilizing recombinant kinesin antigen (rK39) is commercially available to aid in the diagnosis. Visceral leishmaniasis should be considered in the differential diagnosis of veterans with chronic fever and weight loss without any obvious cause. (See  <a class="medical medical_review" href="/d/html/5732.html" rel="external">"Visceral leishmaniasis: Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H4770870"><span class="h2">Q fever</span><span class="headingEndMark"> — </span>Q fever is a zoonotic infection due to <em>Coxiella burnetii</em>, with both acute and chronic manifestations. The incubation period is relatively short, so the acute presentation of Q fever as a self-limited flu-like illness, pneumonia, or hepatitis is typically seen while soldiers are still deployed or immediately following return [<a href="#rid106">106</a>]. However, it can also present as a chronic infection, most commonly as endocarditis which is the most serious and potentially fatal form. Q fever should be considered in all cases of blood culture-negative endocarditis in returning veterans. Further information regarding Q fever can be found from the United States <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fqfever%2Fhealthcare-providers%2Findex.html&amp;token=JesNUNaJCNOJVQWCCy%2BywE9kqc5IU385wxveHccQyRSfy2l%2Fi1Nn583eHrl95FWC%2BYgb2SZ9DkIEVM4LBxkNAg%3D%3D&amp;TOPIC_ID=15782" target="_blank">Centers for Disease Control and Prevention</a> [<a href="#rid107">107</a>].</p><p class="headingAnchor" id="H4770906"><span class="h2">Brucellosis</span><span class="headingEndMark"> — </span>Brucellosis is a zoonotic infection endemic to Afghanistan and Iraq that can vary widely in clinical presentation, ranging from asymptomatic, to insidious onset of non-specific findings, to acute illness and death [<a href="#rid95">95</a>]. The incubation period is usually one to four weeks. A presumptive diagnosis of brucellosis can be made by demonstrating high or rising titers of specific antibodies in the serum in the presence of clinical manifestations.<sup> </sup>This is the most commonly used diagnostic method in clinical practice. The diagnosis of brucellosis is made with certainty when brucellae are isolated from blood, bone marrow, or other body fluids or tissues. Brucellosis should be considered in the differential diagnosis of a fever of unknown origin in veterans who have recently returned from deployment. (See  <a class="medical medical_review" href="/d/html/3140.html" rel="external">"Brucellosis: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H4770913"><span class="h2">Anthrax and smallpox vaccinations</span><span class="headingEndMark"> — </span>Despite controversy regarding the utility of <a class="drug drug_general" data-topicid="8625" href="/d/drug information/8625.html" rel="external">anthrax vaccine</a> and <a class="drug drug_general" data-topicid="10175" href="/d/drug information/10175.html" rel="external">smallpox vaccine</a>, both have been administrated broadly in several military populations [<a href="#rid108">108,109</a>]. While there can be serious short-term side effects following vaccination, no long-term complications have been described following smallpox or anthrax vaccination [<a href="#rid110">110-112</a>]. (See  <a class="medical medical_review" href="/d/html/8296.html" rel="external">"Vaccines to prevent smallpox, mpox (monkeypox), and other orthopoxviruses"</a> and  <a class="medical medical_review" href="/d/html/5535.html" rel="external">"Prevention of anthrax"</a>.)</p><p class="headingAnchor" id="H46284381"><span class="h2">Transfusion-related infections</span><span class="headingEndMark"> — </span>Hemorrhage is the leading preventable cause of mortality in combat casualties [<a href="#rid113">113</a>], and death from hemorrhage usually occurs within 6 to 24 hours of injury [<a href="#rid114">114,115</a>]. Blood products to replace losses must be available at military treatment facilities, which are often located in austere conditions. Stored red blood cells, frozen plasma, and cryoprecipitate products used in battle are fully compliant with US Food and Drug Administration (FDA) regulations. Platelets have a short shelf life and cannot be collected, tested, and transported in time for use for most casualties.</p><p>In some cases, transfusion requirements of one or more casualties exceed the supplies of stored blood components and blood components that have been prescreened for transfusion-transmitted infectious pathogens in accordance with FDA regulations are unavailable [<a href="#rid116">116</a>]. To address the need for life-saving blood products in such conditions, non-FDA-compliant, voluntarily donated, and freshly collected blood products (whole blood and apheresis platelets) may be needed [<a href="#rid117">117,118</a>]. Donors of emergency blood products are usually United States service members located near the receiving medical unit. (See  <a class="medical medical_review" href="/d/html/7949.html" rel="external">"Blood donor screening: Overview of recipient and donor protections"</a>.)</p><p>Countermeasures to reduce the risk of transfusion-transmitted infections have been implemented to include human immunodeficiency virus (HIV) screening of personnel prior to deployment, compulsory hepatitis B virus (HBV) vaccination, donor questionnaire forms to screen for high-risk exposure history, and rapid diagnostic testing for HIV, HBV, and hepatitis C virus (HCV). As apheresis platelets can be donated relatively frequently, pedigree donors who have previously been screened are used preferentially. However, there remains residual risk for transfusion-transmitted infections [<a href="#rid119">119,120</a>].</p><p>US Department of Defense policy requires screening recipients of non-FDA-compliant blood products (specifically fresh whole blood or apheresis platelets collected on site) for HIV, HBV, HCV, human T-lymphotropic virus (HTLV), and rapid plasma reagin (RPR) at 3, 6, and 12 months following the transfusion [<a href="#rid121">121</a>]. Soldiers are given notification when they have received an emergency blood transfusion and are provided with a letter containing an explanation of required screening tests. Soldiers are advised to keep the letter and provide a copy to their clinicians who are providing follow-up care.</p><p class="headingAnchor" id="H4770934"><span class="h1">ENVIRONMENTAL HAZARDS</span></p><p class="headingAnchor" id="H46284479"><span class="h2">Noise exposure</span><span class="headingEndMark"> — </span>Noise-related hearing loss and tinnitus are two of the most prevalent service-connected disabilities among United States veterans [<a href="#rid122">122,123</a>]. United States soldiers have mandatory audiology screening prior to deployment to provide a baseline hearing assessment, and audiology testing is performed if returning veterans report hearing loss or tinnitus. It is reasonable to assess for hearing loss and tinnitus in returning veterans and refer for audiology evaluation if either is present. (See  <a class="medical medical_review" href="/d/html/6850.html" rel="external">"Evaluation of hearing loss in adults"</a> and  <a class="medical medical_review" href="/d/html/6855.html" rel="external">"Etiology and diagnosis of tinnitus"</a>.)</p><p>The United States National Center for Rehabilitative Auditory Research has developed a computer-based, multimedia hearing loss prevention program for military personnel. Its focus is to encourage veterans to employ hearing protective strategies on a regular basis. Its availability is being expanded to veterans via the Internet and at medical centers throughout the United States [<a href="#rid124">124</a>].</p><p class="headingAnchor" id="H4770942"><span class="h2">Toxins</span><span class="headingEndMark"> — </span>Concerns have been raised about exposures to environmental toxins leading to adverse health effects. These hazards include Agent Orange (dioxin) [<a href="#rid125">125</a>], other toxic nerve agents (eg, sarin, cyclosarin) [<a href="#rid126">126,127</a>], and heavy metals [<a href="#rid128">128</a>]. Sulfur mustards (mustard gas) have been used in multiple conflicts including the Iran-Iraq war, and long-term effects of exposure may include pulmonary, dermal, and ocular disease [<a href="#rid129">129,130</a>]. We recommend that returning veterans be queried regarding potential exposure to toxins.</p><p>In recognition of these adverse health effects, in 2022, the Promise to Address Comprehensive Toxics (PACT) Act expanded VA health care and benefits for veterans exposed to burn pits, Agent Orange, and other toxins. Information on the conditions covered and specific eligibility requirements are provided <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.va.gov%2Fresources%2Fthe-pact-act-and-your-va-benefits%2F%3Futm_source%3Dgoogle%26utm_medium%3Dpaid_search%26utm_campaign%3Dar_pact_fy22_vietvets%26gclid%3DCjwKCAiAheacBhB8EiwAItVO2zVErwN9QTHUBzi6DL7P86_y1J-A_Q_Oij7t2V8xkY3hkdP4ZUn08BoCwFUQAvD_BwE&amp;token=F86RJGQmLLVdAzK1DS62CAvWq1rgdIOnKfbj9QKD%2F8nQE3EZypIAuVZo8FMVLbRIpqY5yfSe4DvDh05FtMgZFrmLkm6%2BPBmRjZbX7jKthvCSQHCwOQS37VQkQ92jIo%2Fedkqr3ZUG1ccPHxL0%2FxXwdRjfff5lbUyusBtKlUks2PhLF3PXClT%2BS2mGdg%2F3t%2FtbHRF2UoMv1CAOVUd6CbJ%2FwmjYWuY6PcY3ielX1NX2VlHZNcVj4HH6pGvGpe0mDdXVBvZqtJaje4%2FQ4EIeYAO89CWjxAJFHVwrut8CCVLs4uE%3D&amp;TOPIC_ID=15782" target="_blank">online</a>.</p><p>The VA has added more than 20 burn pit and other toxic exposure presumptive conditions based on the PACT Act [<a href="#rid131">131</a>]. “Burn pits” are constructed holes in the ground used for incineration of garbage and waste. While the Department of Defense now prohibits the use of open burn pits for disposal of waste unless there is no feasible alternative, burn pits were commonly used in South and Southwest Asia during operations in Iraq and Afghanistan, particularly through the mid-2010s. The VA created an Airborne Hazards and Open Burn Pit Registry to identify long-term adverse health outcomes associated with airborne hazards and burn pits. If veterans served in any of the listed locations and time periods, there is presumption that the veteran had exposure to burn pits or other toxins.</p><p>Veterans with burn pit exposure who have longstanding dyspnea, exercise-intolerance, or cough should be evaluated for deployment-related respiratory disease, particularly constrictive bronchiolitis, as well as for more common causes of these symptoms [<a href="#rid132">132-134</a>]. (See  <a class="medical medical_review" href="/d/html/4323.html" rel="external">"Overview of bronchiolar disorders in adults", section on 'Evaluation'</a>.)</p><p>The herbicide Agent Orange has received considerable attention due to widespread use in the Vietnam War by the United States for military purposes [<a href="#rid135">135</a>]. The long-term health effects of Agent Orange are controversial, but an association with certain cancers, including prostate cancer, soft tissue sarcomas, and non-Hodgkin lymphoma, has been reported [<a href="#rid136">136,137</a>]. The National Academy of Medicine (NAM) in the United States biennially updates a comprehensive report on the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fnap.nationalacademies.org%2Fcatalog%2F13166%2Fveterans-and-agent-orange-update-2010&amp;token=ywOvOCOwdRnQ4HgRLwbtJ52WG4yuQwbs7E%2Br7E0U1cmer8VXtC7XZeITbMsJ8SCuVlB1xZc0mhKxKNU5eenqRJAhy9yzY%2B9sVt88C14KlOavALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=15782" target="_blank">health consequences of Agent Orange</a> exposure, based on ongoing evaluation.</p><p>Numerous environmental exposures, including oil well fires, toxic nerve agents, and insect repellents, have been postulated to be associated with persistent symptoms in Persian Gulf War veterans called “Gulf War illness” (also known as “Gulf War Syndrome”), but no single etiological factor has been found to account for these medically unexplained symptoms [<a href="#rid138">138-141</a>]. A report from the NAM in the United States notes that exposure to environmental factors such as oil well fire fumes could represent contributing factors but also notes that similar symptoms have been reported from many other wars in which such factors were not necessarily present [<a href="#rid142">142</a>]. Common symptoms of Gulf War illness include headache, fatigue, joint pain/stiffness, cognitive difficulties, and insomnia [<a href="#rid143">143</a>]. The NAM reviewed efforts to establish a case definition for Gulf War illness and found that none were entirely satisfactory but that one from the US Centers for Disease Control and Prevention (CDC) [<a href="#rid144">144</a>] and another from Kansas [<a href="#rid145">145</a>] seemed to have the greatest utility and applicability.</p><p>Although the safety of independent use of insect repellents diethyl-meta-toluamide (DEET) and <a class="drug drug_general" data-topicid="9759" href="/d/drug information/9759.html" rel="external">permethrin</a> is well documented [<a href="#rid146">146,147</a>], concerns were raised during the Persian Gulf War in the early 1990s after animal studies found that concomitant use of these insect repellants with <a class="drug drug_general" data-topicid="9838" href="/d/drug information/9838.html" rel="external">pyridostigmine</a> bromide (used as prophylaxis against nerve agent exposure) was associated with chronic neurotoxic syndromes [<a href="#rid148">148</a>]. A subsequent randomized trial in humans compared appropriate doses of all three treatments in combination compared with placebo and found no adverse effects [<a href="#rid149">149</a>]. However, fears spawned by the earlier animal studies have occasionally led service members to forgo the use of insect repellents, resulting in higher rates of malaria and other insect-borne diseases compared with those who regularly use the combination of permethrin treatment of clothing and DEET application to the skin. Veterans who may be deployed should be counseled on the benefits and safety of insect repellant use. (See  <a class="medical medical_review" href="/d/html/4085.html" rel="external">"Prevention of arthropod and insect bites: Repellents and other measures"</a>.)</p><p class="headingAnchor" id="H4769426"><span class="h1">DISABILITY AND FUNCTIONAL ASSESSMENT</span><span class="headingEndMark"> — </span>In 2010, the United States Census Bureau reported that there were a total of 22.0 million living veterans in the United States, of which 3.2 million veterans received service connected disability compensation [<a href="#rid150">150</a>].</p><p>Functional capacity assessments are commonly performed by military treating facilities (including the United States Veterans Administration [VA] Hospitals). If the veteran has symptoms or signs of functional or mobility problems, then physical, occupational, and/or speech therapy evaluations should be conducted. (See  <a class="medical medical_review" href="/d/html/2791.html" rel="external">"Disability assessment and determination in the United States"</a>.)</p><p>Military members in the United States who have physical and/or mental health conditions that render them unfit to perform their required duties are reviewed by a Medical Evaluation Board. The board consists of active-duty clinicians (not involved in the care of the military member) who review the clinical case file and decide whether the individual should be returned to duty, or should be separated, using published medical standards for continued military service (Army Regulation 40-501 Standards of Medical Fitness, SECNAVINST 1850.4E Navy Disability Evaluation Manual) [<a href="#rid151">151</a>]. If the member's medical condition falls below medical retention standards, the case is forwarded to a Physical Evaluation Board (PEB). The PEB is a formal fitness-for-duty and disability determination that may recommend return of the member to duty (with or without assignment limitations which are documented and outlined in a "physical profile"), transfer of the member from active duty, or medical retirement of the member temporarily or permanently. The standard used by the PEB for determining fitness is whether the medical condition precludes the member from reasonably performing the duties of his or her office, rank, or position. Military members who are separated or medically retired are given a disability rating by the PEB based off of the Department of Veterans Affairs Schedule for Rating Disabilities [<a href="#rid152">152</a>].</p><p>Most United States military personnel are active-duty service members and are therefore eligible for care within the Department of Defense military treatment facilities upon their return from deployment. However, more than one-quarter of those who have been deployed are National Guard or Reserve service members who are activated specifically for deployment. Health problems or injuries that occur during service, or are deemed to be service connected when identified after deployment, can result in service members being eligible for care in the Department of Defense or VA hospitals/clinics for the remainder of their lives.</p><p class="headingAnchor" id="H46283896"><span class="h1">SOCIAL STRESS</span><span class="headingEndMark"> — </span>Being confronted with "kill or be killed" scenarios, and being on guard day and night for a prolonged period of time, represents an enormous life stressor. This stress can result in a wide variety of physical and psychological symptoms that may become apparent at home and persist for months to years, if not indefinitely. Deployment has a significant impact not only on military service members, but also on their families [<a href="#rid153">153,154</a>].</p><p>Stressors on families include the separation from a parent or caregiver who would otherwise be providing childcare, the remaining caregiver left behind having to manage all household duties, and fears that the deployed member might be injured or die. Up to half of military families relocate during deployment to be closer to extended families, but this often comes at the price of disruption in school and friendships for children, interruption in employment for the remaining partner, and loss of support that might be provided by the military community or the previous home community [<a href="#rid155">155</a>]. Frequent uncertainty regarding when the service member will deploy, and when they will return home, is a significant source of anxiety. Rates of conflict, intimate partner violence, and divorce are higher in families where a member has been deployed [<a href="#rid156">156,157</a>]. In caring for a returning veteran, the clinician should evaluate the situation at home, paying attention to the veteran's marital/partner, parental, and community relationships.</p><p class="headingAnchor" id="H46283973"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>One important resource for helping veterans and their families cope with deployment stress is <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.focusproject.org%2F&amp;token=O8Srbn%2FnXUHhavPEvCh9D%2FiMJEIw6Zt6ypTXqcFN2xew%2FeHnHOepOH63oy9we%2BMl&amp;TOPIC_ID=15782" target="_blank">FOCUS</a> (Families Overcoming Under Stress), which provides both on-site support at a number of military bases, as well as online information and tools. FOCUS provides state-of-the-art resiliency training for both children and adult members of military families at various stages, including deployment, return from duty, and redeployment.</p><p class="headingAnchor" id="H616481677"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Although the overall medical care of the returning veteran may be similar to that of the general population, there are certain issues (eg, combat injuries, traumatic brain injury (TBI), posttraumatic stress disorder (PTSD), readjustment to society following deployment) that pertain specifically to the veteran. Physical injuries from combat (eg, amputations, TBI) can lead to significant functional limitations as well as psychological sequelae. (See <a class="local">'Physical injury due to combat'</a> above and <a class="local">'Psychological sequelae'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>PTSD and other psychological sequelae in veterans are being identified at higher rates than in the past. Psychological symptoms are frequently not fully manifest until months or years after return from deployment. An initial screening shortly after return from deployment will miss most cases of mental health problems and repeated screening is necessary, especially between 3 and 12 months after return. (See <a class="local">'Screening for psychological sequelae'</a> above.)</p><p></p><p class="bulletIndent1">Returning veterans should be screened for:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>PTSD  (<a class="graphic graphic_table graphicRef105765" href="/d/graphic/105765.html" rel="external">table 2</a>) (see  <a class="medical medical_review" href="/d/html/500.html" rel="external">"Posttraumatic stress disorder in adults: Epidemiology, pathophysiology, clinical features, assessment, and diagnosis", section on 'Screening'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Depression  (<a class="graphic graphic_table graphicRef59307" href="/d/graphic/59307.html" rel="external">table 3</a>) (see  <a class="medical medical_review" href="/d/html/1721.html" rel="external">"Unipolar depression in adults: Assessment and diagnosis", section on 'Screening for depression'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Anxiety disorders  (<a class="graphic graphic_table graphicRef77755" href="/d/graphic/77755.html" rel="external">table 4</a>) (see  <a class="medical medical_review" href="/d/html/496.html" rel="external">"Generalized anxiety disorder in adults: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis", section on 'Screening, assessment, and diagnosis'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Alcohol and substance use disorder (see  <a class="medical medical_review" href="/d/html/14843.html" rel="external">"Screening for unhealthy use of alcohol and other drugs in primary care", section on 'Screening tests'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Veterans who screen positive for PTSD, depression, or anxiety should also be asked about suicidal ideation and intent; if present, the lethality of the plan should be evaluated. Veterans at imminent risk for suicide require immediate psychiatric services and must be monitored continuously until they are no longer an immediate suicide risk. (See <a class="local">'Suicide'</a> above and  <a class="medical medical_review" href="/d/html/1708.html" rel="external">"Suicidal ideation and behavior in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Veterans are at risk for a wide range of infectious diseases depending upon the particular area of deployment. (See <a class="local">'Infectious diseases'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Noise-related hearing loss and tinnitus are two of the most prevalent service-connected disabilities among United States veterans. Other environmental exposures such as toxic nerve agents have been documented in previous wars but have not been implicated in the more recent wars in Afghanistan and Iraq. (See <a class="local">'Environmental hazards'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If the veteran has symptoms or signs of functional or mobility problems, then physical and occupational therapy evaluations should be conducted. (See <a class="local">'Disability and functional assessment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Finally, the clinician should evaluate the situation at home, paying attention to the veteran's familial and community relationships, as veterans are prone to have difficulties in the transition back to civilian life (see <a class="local">'Social stress'</a> above). Efforts should be made to address any barriers to care and to enlist the help of interdisciplinary teams (eg, psychiatry, physical therapy, social work) in this goal.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Landrum ML, Murray CK. Ventilator associated pneumonia in a military deployed setting: the impact of an aggressive infection control program. J Trauma 2008; 64:S123.</a></li><li><a class="nounderline abstract_t">Sharrock AE, Tai N, Perkins Z, et al. Management and outcome of 597 wartime penetrating lower extremity arterial injuries from an international military cohort. J Vasc Surg 2019; 70:224.</a></li><li><a class="nounderline abstract_t">Stewart IJ, Sosnov JA, Howard JT, et al. Retrospective Analysis of Long-Term Outcomes After Combat Injury: A Hidden Cost of War. Circulation 2015; 132:2126.</a></li><li><a class="nounderline abstract_t">Wojcik BE, Humphrey RJ, Czejdo B, Hassell LH. U.S. Army disease and nonbattle injury model, refined in Afghanistan and Iraq. Mil Med 2008; 173:825.</a></li><li><a class="nounderline abstract_t">Roy MJ, Koslowe PA, Kroenke K, Magruder C. Signs, symptoms, and ill-defined conditions in Persian Gulf War veterans: findings from the Comprehensive Clinical Evaluation Program. Psychosom Med 1998; 60:663.</a></li><li><a class="nounderline abstract_t">Schauer SG, April MD, Fisher AD, et al. Junctional Tourniquet Use During Combat Operations in Afghanistan: The Prehospital Trauma Registry Experience. J Spec Oper Med Summer; 18:71.</a></li><li><a class="nounderline abstract_t">Peng HT. Hemostatic agents for prehospital hemorrhage control: a narrative review. Mil Med Res 2020; 7:13.</a></li><li><a class="nounderline abstract_t">Minei JP, Schmicker RH, Kerby JD, et al. Severe traumatic injury: regional variation in incidence and outcome. Ann Surg 2010; 252:149.</a></li><li class="breakAll">War Surgery in Afghanistan and Iraq: A Series of Cases, 2003–2007, Nessen SC, Lounsbury DE, Hetz SP (Eds), Department of the Army, Washington, DC 2008.</li><li><a class="nounderline abstract_t">Stansbury LG, Lalliss SJ, Branstetter JG, et al. Amputations in U.S. military personnel in the current conflicts in Afghanistan and Iraq. J Orthop Trauma 2008; 22:43.</a></li><li class="breakAll">Care of the combat amputee, Lenhart MK, Pasquina PF, Cooper RA (Eds), Office of The Surgeon General and US Medical Department Center and School 2009. Available at: https://medcoe.army.mil/borden-tb-care-combat-amputee (Accessed on June 01, 2021).</li><li><a class="nounderline abstract_t">Reiber GE, McFarland LV, Hubbard S, et al. Servicemembers and veterans with major traumatic limb loss from Vietnam war and OIF/OEF conflicts: survey methods, participants, and summary findings. J Rehabil Res Dev 2010; 47:275.</a></li><li><a class="nounderline abstract_t">Hoge CW, McGurk D, Thomas JL, et al. Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N Engl J Med 2008; 358:453.</a></li><li><a class="nounderline abstract_t">Mac Donald CL, Johnson AM, Cooper D, et al. Detection of blast-related traumatic brain injury in U.S. military personnel. N Engl J Med 2011; 364:2091.</a></li><li><a class="nounderline abstract_t">Hoge CW, Castro CA. Treatment of generalized war-related health concerns: placing TBI and PTSD in context. JAMA 2014; 312:1685.</a></li><li><a class="nounderline abstract_t">Dunbar KE, Raboy AL, Kirby ZM, et al. Distinguishing the Relative Impact of Post-Traumatic Stress Disorder and Traumatic Brain Injury on iPad-Measured Cognitive Function. Cyberpsychol Behav Soc Netw 2019; 22:761.</a></li><li><a class="nounderline abstract_t">Giacino JT, Whyte J, Bagiella E, et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med 2012; 366:819.</a></li><li><a class="nounderline abstract_t">Wojcik BE, Curley KC, Szeszel-Fedorowicz W, et al. Spinal injury hospitalizations among U.S. Army soldiers deployed to Iraq and Afghanistan. Mil Med 2015; 180:216.</a></li><li><a class="nounderline abstract_t">Justin GA, Baker KM, Brooks DI, et al. Intraocular Foreign Body Trauma in Operation Iraqi Freedom and Operation Enduring Freedom: 2001 to 2011. Ophthalmology 2018; 125:1675.</a></li><li><a class="nounderline abstract_t">Grieger TA, Cozza SJ, Ursano RJ, et al. Posttraumatic stress disorder and depression in battle-injured soldiers. Am J Psychiatry 2006; 163:1777.</a></li><li><a class="nounderline abstract_t">Thomas JL, Wilk JE, Riviere LA, et al. Prevalence of mental health problems and functional impairment among active component and National Guard soldiers 3 and 12 months following combat in Iraq. Arch Gen Psychiatry 2010; 67:614.</a></li><li><a class="nounderline abstract_t">Rona RJ, Burdett H, Khondoker M, et al. Post-deployment screening for mental disorders and tailored advice about help-seeking in the UK military: a cluster randomised controlled trial. Lancet 2017; 389:1410.</a></li><li><a class="nounderline abstract_t">Hoge CW, Castro CA, Messer SC, et al. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med 2004; 351:13.</a></li><li><a class="nounderline abstract_t">Knox KL, Litts DA, Talcott GW, et al. Risk of suicide and related adverse outcomes after exposure to a suicide prevention programme in the US Air Force: cohort study. BMJ 2003; 327:1376.</a></li><li><a class="nounderline abstract_t">Bryan CJ, Rozek DC. Suicide prevention in the military: a mechanistic perspective. Curr Opin Psychol 2018; 22:27.</a></li><li><a class="nounderline abstract_t">Cohen BE, Marmar C, Ren L, et al. Association of cardiovascular risk factors with mental health diagnoses in Iraq and Afghanistan war veterans using VA health care. JAMA 2009; 302:489.</a></li><li><a class="nounderline abstract_t">Howard JT, Sosnov JA, Janak JC, et al. Associations of Initial Injury Severity and Posttraumatic Stress Disorder Diagnoses With Long-Term Hypertension Risk After Combat Injury. Hypertension 2018; 71:824.</a></li><li><a class="nounderline abstract_t">Seal KH, Metzler TJ, Gima KS, et al. Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002-2008. Am J Public Health 2009; 99:1651.</a></li><li><a class="nounderline abstract_t">Hoge CW, Auchterlonie JL, Milliken CS. Mental health problems, use of mental health services, and attrition from military service after returning from deployment to Iraq or Afghanistan. JAMA 2006; 295:1023.</a></li><li><a class="nounderline abstract_t">Andrews B, Brewin CR, Philpott R, Stewart L. Delayed-onset posttraumatic stress disorder: a systematic review of the evidence. Am J Psychiatry 2007; 164:1319.</a></li><li class="breakAll">Weathers FW, Juska JA, Keane TM. The PTSD checklist - civilian version. Boston National Center for PTSD. Boston Veterans Affairs Medical Center 1991.</li><li class="breakAll">US Department of Veterans Affairs. PTSD: National center for PTSD. Available at: https://www.ptsd.va.gov/understand/isitptsd/measured_how.asp (Accessed on June 10, 2021).</li><li><a class="nounderline abstract_t">Blore JD, Sim MR, Forbes AB, et al. Depression in Gulf War veterans: a systematic review and meta-analysis. Psychol Med 2015; 45:1565.</a></li><li><a class="nounderline abstract_t">Bonde JP, Utzon-Frank N, Bertelsen M, et al. Risk of depressive disorder following disasters and military deployment: systematic review with meta-analysis. Br J Psychiatry 2016; 208:330.</a></li><li><a class="nounderline abstract_t">Scherrer JF, Chrusciel T, Zeringue A, et al. Anxiety disorders increase risk for incident myocardial infarction in depressed and nondepressed Veterans Administration patients. Am Heart J 2010; 159:772.</a></li><li><a class="nounderline abstract_t">Mittal D, Fortney JC, Pyne JM, Wetherell JL. Predictors of persistence of comorbid generalized anxiety disorder among veterans with major depressive disorder. J Clin Psychiatry 2011; 72:1445.</a></li><li class="breakAll">US Department of Veterans Affairs. Mental health: Suicide prevention. Available at: https://www.mentalhealth.va.gov/mentalhealth/suicide_prevention/data.asp (Accessed on June 10, 2021).</li><li><a class="nounderline abstract_t">Pietrzak RH, Goldstein MB, Malley JC, et al. Risk and protective factors associated with suicidal ideation in veterans of Operations Enduring Freedom and Iraqi Freedom. J Affect Disord 2010; 123:102.</a></li><li><a class="nounderline abstract_t">Pruitt LD, Smolenski DJ, Bush NE, et al. Suicide in the Military: Understanding Rates and Risk Factors Across the United States' Armed Forces. Mil Med 2019; 184:432.</a></li><li><a class="nounderline abstract_t">Kessler RC, Warner CH, Ivany C, et al. Predicting suicides after psychiatric hospitalization in US Army soldiers: the Army Study To Assess Risk and rEsilience in Servicemembers (Army STARRS). JAMA Psychiatry 2015; 72:49.</a></li><li><a class="nounderline abstract_t">LeardMann CA, Powell TM, Smith TC, et al. Risk factors associated with suicide in current and former US military personnel. JAMA 2013; 310:496.</a></li><li><a class="nounderline abstract_t">Reger MA, Smolenski DJ, Skopp NA, et al. Risk of Suicide Among US Military Service Members Following Operation Enduring Freedom or Operation Iraqi Freedom Deployment and Separation From the US Military. JAMA Psychiatry 2015; 72:561.</a></li><li><a class="nounderline abstract_t">Lynch KE, Gatsby E, Viernes B, et al. Evaluation of Suicide Mortality Among Sexual Minority US Veterans From 2000 to 2017. JAMA Netw Open 2020; 3:e2031357.</a></li><li><a class="nounderline abstract_t">Schoenbaum M, Kessler RC, Gilman SE, et al. Predictors of suicide and accident death in the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS): results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS). JAMA Psychiatry 2014; 71:493.</a></li><li><a class="nounderline abstract_t">Fonda JR, Fredman L, Brogly SB, et al. Traumatic Brain Injury and Attempted Suicide Among Veterans of the Wars in Iraq and Afghanistan. Am J Epidemiol 2017; 186:220.</a></li><li><a class="nounderline abstract_t">Gilman SE, Bromet EJ, Cox KL, et al. Sociodemographic and career history predictors of suicide mortality in the United States Army 2004-2009. Psychol Med 2014; 44:2579.</a></li><li><a class="nounderline abstract_t">Conner KR, Bossarte RM, He H, et al. Posttraumatic stress disorder and suicide in 5.9 million individuals receiving care in the veterans health administration health system. J Affect Disord 2014; 166:1.</a></li><li><a class="nounderline abstract_t">Sher L, Braquehais MD, Casas M. Posttraumatic stress disorder, depression, and suicide in veterans. Cleve Clin J Med 2012; 79:92.</a></li><li><a class="nounderline abstract_t">Rudd MD, Bryan CJ, Wertenberger EG, et al. Brief cognitive-behavioral therapy effects on post-treatment suicide attempts in a military sample: results of a randomized clinical trial with 2-year follow-up. Am J Psychiatry 2015; 172:441.</a></li><li><a class="nounderline abstract_t">Engel CC. Suicide, mental disorders, and the US military: time to focus on mental health service delivery. JAMA 2013; 310:484.</a></li><li><a class="nounderline abstract_t">Smith EG, Kim HM, Ganoczy D, et al. Suicide risk assessment received prior to suicide death by Veterans Health Administration patients with a history of depression. J Clin Psychiatry 2013; 74:226.</a></li><li><a class="nounderline abstract_t">Bossarte RM, Claassen CA, Knox KL. Evaluating evidence of risk for suicide among veterans. Mil Med 2010; 175:703.</a></li><li class="breakAll">Suicide prevention. Military Health System. Available at: https://www.health.mil/Military-Health-Topics/MHS-Toolkits/May-Toolkit/Suicide-Prevention (Accessed on June 10, 2021).</li><li><a class="nounderline abstract_t">Sall J, Brenner L, Millikan Bell AM, Colston MJ. Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines. Ann Intern Med 2019; 171:343.</a></li><li><a class="nounderline abstract_t">Epstein RA, Heinemann AW, McFarland LV. Quality of life for veterans and servicemembers with major traumatic limb loss from Vietnam and OIF/OEF conflicts. J Rehabil Res Dev 2010; 47:373.</a></li><li><a class="nounderline abstract_t">Horgan O, MacLachlan M. Psychosocial adjustment to lower-limb amputation: a review. Disabil Rehabil 2004; 26:837.</a></li><li><a class="nounderline abstract_t">Desmond DM. Coping, affective distress, and psychosocial adjustment among people with traumatic upper limb amputations. J Psychosom Res 2007; 62:15.</a></li><li><a class="nounderline abstract_t">Seel RT, Kreutzer JS, Rosenthal M, et al. Depression after traumatic brain injury: a National Institute on Disability and Rehabilitation Research Model Systems multicenter investigation. Arch Phys Med Rehabil 2003; 84:177.</a></li><li><a class="nounderline abstract_t">Jorge RE, Robinson RG, Moser D, et al. Major depression following traumatic brain injury. Arch Gen Psychiatry 2004; 61:42.</a></li><li><a class="nounderline abstract_t">Kennedy RE, Livingston L, Riddick A, et al. Evaluation of the Neurobehavioral Functioning Inventory as a depression screening tool after traumatic brain injury. J Head Trauma Rehabil 2005; 20:512.</a></li><li><a class="nounderline abstract_t">Kennedy JE, Lu LH, Reid MW, et al. Correlates of Depression in U.S. Military Service Members With a History of Mild Traumatic Brain Injury. Mil Med 2019; 184:148.</a></li><li><a class="nounderline abstract_t">Schneiderman AI, Braver ER, Kang HK. Understanding sequelae of injury mechanisms and mild traumatic brain injury incurred during the conflicts in Iraq and Afghanistan: persistent postconcussive symptoms and posttraumatic stress disorder. Am J Epidemiol 2008; 167:1446.</a></li><li><a class="nounderline abstract_t">Spelman JF, Hunt SC, Seal KH, Burgo-Black AL. Post deployment care for returning combat veterans. J Gen Intern Med 2012; 27:1200.</a></li><li><a class="nounderline abstract_t">Taylor BC, Hagel EM, Carlson KF, et al. Prevalence and costs of co-occurring traumatic brain injury with and without psychiatric disturbance and pain among Afghanistan and Iraq War Veteran V.A. users. Med Care 2012; 50:342.</a></li><li class="breakAll">Committee on the Development of a Consensus Case Definition for Chronic Multisymptom Illness in 1990. Chronic Multisymptom Illness in Gulf War Veterans: Case Definitions Reexamined, National Academies Press, Washington 2014.</li><li class="breakAll">Committee on Gulf War and Health: Treatment for Chronic Multisymptom Illness, Board on the Health of. Gulf War and Health: Treatment for Chronic Multisymptom Illness, National Academies Press, Washington 2013.</li><li><a class="nounderline abstract_t">Smith TC, Powell TM, Jacobson IG, et al. Chronic multisymptom illness: a comparison of Iraq and Afghanistan deployers with veterans of the 1991 Gulf War. Am J Epidemiol 2014; 180:1176.</a></li><li><a class="nounderline abstract_t">Mohanty AF, McAndrew LM, Helmer D, et al. Chronic Multisymptom Illness Among Iraq/Afghanistan-Deployed US Veterans and Their Healthcare Utilization Within the Veterans Health Administration. J Gen Intern Med 2018; 33:1419.</a></li><li><a class="nounderline abstract_t">Kearney DJ, Simpson TL, Malte CA, et al. Mindfulness-based Stress Reduction in Addition to Usual Care Is Associated with Improvements in Pain, Fatigue, and Cognitive Failures Among Veterans with Gulf War Illness. Am J Med 2016; 129:204.</a></li><li><a class="nounderline abstract_t">Murphy LB, Helmick CG, Allen KD, et al. Arthritis among veterans - United States, 2011-2013. MMWR Morb Mortal Wkly Rep 2014; 63:999.</a></li><li><a class="nounderline abstract_t">Dobscha SK, Corson K, Perrin NA, et al. Collaborative care for chronic pain in primary care: a cluster randomized trial. JAMA 2009; 301:1242.</a></li><li><a class="nounderline abstract_t">Bair MJ, Ang D, Wu J, et al. Evaluation of Stepped Care for Chronic Pain (ESCAPE) in Veterans of the Iraq and Afghanistan Conflicts: A Randomized Clinical Trial. JAMA Intern Med 2015; 175:682.</a></li><li><a class="nounderline abstract_t">Morasco BJ, O'Hearn D, Turk DC, Dobscha SK. Associations between prescription opioid use and sleep impairment among veterans with chronic pain. Pain Med 2014; 15:1902.</a></li><li><a class="nounderline abstract_t">Edlund MJ, Austen MA, Sullivan MD, et al. Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011. Pain 2014; 155:2337.</a></li><li><a class="nounderline abstract_t">Zedler B, Xie L, Wang L, et al. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients. Pain Med 2014; 15:1911.</a></li><li><a class="nounderline abstract_t">Higgins DM, Kerns RD, Brandt CA, et al. Persistent pain and comorbidity among Operation Enduring Freedom/Operation Iraqi Freedom/operation New Dawn veterans. Pain Med 2014; 15:782.</a></li><li><a class="nounderline abstract_t">Seal KH, Shi Y, Cohen G, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA 2012; 307:940.</a></li><li><a class="nounderline abstract_t">Stratton KJ, Clark SL, Hawn SE, et al. Longitudinal interactions of pain and posttraumatic stress disorder symptoms in U.S. Military service members following blast exposure. J Pain 2014; 15:1023.</a></li><li><a class="nounderline abstract_t">Bray RM, Pemberton MR, Lane ME, et al. Substance use and mental health trends among U.S. military active duty personnel: key findings from the 2008 DoD Health Behavior Survey. Mil Med 2010; 175:390.</a></li><li><a class="nounderline abstract_t">Bray RM, Hourani LL. Substance use trends among active duty military personnel: findings from the United States Department of Defense Health Related Behavior Surveys, 1980-2005. Addiction 2007; 102:1092.</a></li><li><a class="nounderline abstract_t">Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2007; 64:566.</a></li><li><a class="nounderline abstract_t">Seal KH, Cohen G, Waldrop A, et al. Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001-2010: Implications for screening, diagnosis and treatment. Drug Alcohol Depend 2011; 116:93.</a></li><li><a class="nounderline abstract_t">Norman SB, Haller M, Hamblen JL, et al. The burden of co-occurring alcohol use disorder and PTSD in U.S. Military veterans: Comorbidities, functioning, and suicidality. Psychol Addict Behav 2018; 32:224.</a></li><li><a class="nounderline abstract_t">Wagner TH, Harris KM, Federman B, et al. Prevalence of substance use disorders among veterans and comparable nonveterans from the National Survey on Drug Use and Health. Psychological Services 2007; 4:149.</a></li><li><a class="nounderline abstract_t">Hawkins EJ, Lapham GT, Kivlahan DR, Bradley KA. Recognition and management of alcohol misuse in OEF/OIF and other veterans in the VA: a cross-sectional study. Drug Alcohol Depend 2010; 109:147.</a></li><li><a class="nounderline abstract_t">McFall M, Saxon AJ, Thompson CE, et al. Improving the rates of quitting smoking for veterans with posttraumatic stress disorder. Am J Psychiatry 2005; 162:1311.</a></li><li><a class="nounderline abstract_t">McFall M, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA 2010; 304:2485.</a></li><li><a class="nounderline abstract_t">Santiago PN, Wilk JE, Milliken CS, et al. Screening for alcohol misuse and alcohol-related behaviors among combat veterans. Psychiatr Serv 2010; 61:575.</a></li><li><a class="nounderline abstract_t">Wilk JE, Bliese PD, Kim PY, et al. Relationship of combat experiences to alcohol misuse among U.S. soldiers returning from the Iraq war. Drug Alcohol Depend 2010; 108:115.</a></li><li><a class="nounderline abstract_t">Levander XA, Overland MK. Care of women veterans. Med Clin North Am 2015; 99:651.</a></li><li><a class="nounderline abstract_t">Wilson LC. The Prevalence of Military Sexual Trauma: A Meta-Analysis. Trauma Violence Abuse 2018; 19:584.</a></li><li><a class="nounderline abstract_t">Gibson CJ, Maguen S, Xia F, et al. Military Sexual Trauma in Older Women Veterans: Prevalence and Comorbidities. J Gen Intern Med 2020; 35:207.</a></li><li><a class="nounderline abstract_t">Faulde MK, Hoffmann R, Fazilat KM, Hoerauf A. Malaria reemergence in northern Afghanistan. Emerg Infect Dis 2007; 13:1402.</a></li><li><a class="nounderline abstract_t">Croft AM, Darbyshire AH, Jackson CJ, van Thiel PP. Malaria prevention measures in coalition troops in Afghanistan. JAMA 2007; 297:2197.</a></li><li><a class="nounderline abstract_t">Aronson NE, Sanders JW, Moran KA. In harm's way: infections in deployed American military forces. Clin Infect Dis 2006; 43:1045.</a></li><li><a class="nounderline abstract_t">Murray CK, Roop SA, Hospenthal DR, et al. Bacteriology of war wounds at the time of injury. Mil Med 2006; 171:826.</a></li><li><a class="nounderline abstract_t">Johnson EN, Burns TC, Hayda RA, et al. Infectious complications of open type III tibial fractures among combat casualties. Clin Infect Dis 2007; 45:409.</a></li><li><a class="nounderline abstract_t">Dallo SF, Weitao T. Insights into acinetobacter war-wound infections, biofilms, and control. Adv Skin Wound Care 2010; 23:169.</a></li><li><a class="nounderline abstract_t">Warkentien T, Rodriguez C, Lloyd B, et al. Invasive mold infections following combat-related injuries. Clin Infect Dis 2012; 55:1441.</a></li><li><a class="nounderline abstract_t">Weintrob AC, Roediger MP, Barber M, et al. Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol 2010; 31:330.</a></li><li><a class="nounderline abstract_t">Hospenthal DR, Crouch HK, English JF, et al. Multidrug-resistant bacterial colonization of combat-injured personnel at admission to medical centers after evacuation from Afghanistan and Iraq. J Trauma 2011; 71:S52.</a></li><li><a class="nounderline abstract_t">Keen EF 3rd, Murray CK, Robinson BJ, et al. Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center. Infect Control Hosp Epidemiol 2010; 31:728.</a></li><li><a class="nounderline abstract_t">Sensenig RA, Murray CK, Mende K, et al. Longitudinal characterization of Acinetobacter baumannii-calcoaceticus complex, Klebsiella pneumoniae, and methicillin-resistant Staphylococcus aureus colonizing and infecting combat casualties. Am J Infect Control 2012; 40:183.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Update: Cutaneous leishmaniasis in U.S. military personnel--Southwest/Central Asia, 2002-2004. MMWR Morb Mortal Wkly Rep 2004; 53:264.</a></li><li><a class="nounderline abstract_t">Myles O, Wortmann GW, Cummings JF, et al. Visceral leishmaniasis: clinical observations in 4 US army soldiers deployed to Afghanistan or Iraq, 2002-2004. Arch Intern Med 2007; 167:1899.</a></li><li><a class="nounderline abstract_t">Faix DJ, Harrison DJ, Riddle MS, et al. Outbreak of Q fever among US military in western Iraq, June-July 2005. Clin Infect Dis 2008; 46:e65.</a></li><li><a class="nounderline abstract_t">Anderson A, Bijlmer H, Fournier PE, et al. Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep 2013; 62:1.</a></li><li><a class="nounderline abstract_t">Weiss MM, Weiss PD, Weiss JB. Anthrax vaccine and public health policy. Am J Public Health 2007; 97:1945.</a></li><li><a class="nounderline abstract_t">LeardMann CA, Smith B, Smith TC, et al. Smallpox vaccination: comparison of self-reported and electronic vaccine records in the millennium cohort study. Hum Vaccin 2007; 3:245.</a></li><li><a class="nounderline abstract_t">Casey CG, Iskander JK, Roper MH, et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA 2005; 294:2734.</a></li><li><a class="nounderline abstract_t">Niu MT, Ball R, Woo EJ, et al. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007. Vaccine 2009; 27:290.</a></li><li><a class="nounderline abstract_t">Sulsky SI, Luippold RS, Garman P, et al. Risk of disability for US army personnel vaccinated against anthrax, 1998-2005. Vaccine 2011; 29:6035.</a></li><li><a class="nounderline abstract_t">Kelly JF, Ritenour AE, McLaughlin DF, et al. Injury severity and causes of death from Operation Iraqi Freedom and Operation Enduring Freedom: 2003-2004 versus 2006. J Trauma 2008; 64:S21.</a></li><li><a class="nounderline abstract_t">Peng R, Chang C, Gilmore D, Bongard F. Epidemiology of immediate and early trauma deaths at an urban Level I trauma center. Am Surg 1998; 64:950.</a></li><li><a class="nounderline abstract_t">Demetriades D, Murray J, Charalambides K, et al. Trauma fatalities: time and location of hospital deaths. J Am Coll Surg 2004; 198:20.</a></li><li><a class="nounderline abstract_t">Kauvar DS, Holcomb JB, Norris GC, Hess JR. Fresh whole blood transfusion: a controversial military practice. J Trauma 2006; 61:181.</a></li><li><a class="nounderline abstract_t">Perkins JG, Cap AP, Spinella PC, et al. Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients (CME). Transfusion 2011; 51:242.</a></li><li><a class="nounderline abstract_t">Cap AP, Beckett A, Benov A, et al. Whole Blood Transfusion. Mil Med 2018; 183:44.</a></li><li><a class="nounderline abstract_t">Spinella PC, Perkins JG, Grathwohl KW, et al. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital. Crit Care Med 2007; 35:2576.</a></li><li class="breakAll">Office of the Assistant Secretary of Defense. Policy on the Use of Non-U.S. Food and Drug Administration Compliant Blood Products. US Department of Defense, Washington, DC 2010.</li><li class="breakAll">Rice CL. Memorandum: Policy on the use of non-US Food and Drug Administration compliant blood products. Office of the Assistant Secretary of Defense. 2010. Available at: https://www.health.mil/Reference-Center/Policies/2010/03/19/This-policy-memorandum-provides-guidance-on-the-use-of-and-protocol-for-follow-up-regarding-non-U-S (Accessed on June 01, 2021).</li><li><a class="nounderline abstract_t">Saunders GH, Vachhani JJ, Galvez G, Griest SE. Formative evaluation of a multimedia self-administered computerized hearing loss prevention program. Int J Audiol 2015; 54:234.</a></li><li class="breakAll">US Department of Veterans Affairs. Veterans Benefits Administration reports: Annual benefits report 2019. Available at: https://www.benefits.va.gov/REPORTS/abr/ (Accessed on June 01, 2021).</li><li class="breakAll">US Department of Veterans Affairs. National Center for Rehabilitative Auditory Research (NCRAR). Available at: http://www.ncrar.research.va.gov/aboutus/index.asp (Accessed on June 01, 2021).</li><li><a class="nounderline abstract_t">Bullman TA, Kang HK. The effects of mustard gas, ionizing radiation, herbicides, trauma, and oil smoke on US military personnel: the results of veteran studies. Annu Rev Public Health 1994; 15:69.</a></li><li><a class="nounderline abstract_t">Bullman TA, Mahan CM, Kang HK, Page WF. Mortality in US Army Gulf War veterans exposed to 1991 Khamisiyah chemical munitions destruction. Am J Public Health 2005; 95:1382.</a></li><li><a class="nounderline abstract_t">Kang HK, Bullman T. Mortality follow-up of veterans who participated in military chemical and biological warfare agent testing between 1962 and 1972. J Toxicol Environ Health A 2009; 72:1550.</a></li><li><a class="nounderline abstract_t">Ryu H, Han JK, Jung JW, et al. Human health risk assessment of explosives and heavy metals at a military gunnery range. Environ Geochem Health 2007; 29:259.</a></li><li><a class="nounderline abstract_t">Bullman T, Kang H. A fifty year mortality follow-up study of veterans exposed to low level chemical warfare agent, mustard gGas. Ann Epidemiol 2000; 10:333.</a></li><li><a class="nounderline abstract_t">Amini H, Solaymani-Dodaran M, Mousavi B, et al. Long-term Health Outcomes Among Survivors Exposed to Sulfur Mustard in Iran. JAMA Netw Open 2020; 3:e2028894.</a></li><li class="breakAll">US Department of Veterans Affairs. Exposure to burn pits and other specific environmental hazards. Available at: https://www.va.gov/disability/eligibility/hazardous-materials-exposure/specific-environmental-hazards/ (Accessed on January 11, 2023).</li><li><a class="nounderline abstract_t">Falvo MJ, Sotolongo AM, Osterholzer JJ, et al. Consensus Statements on Deployment-Related Respiratory Disease, Inclusive of Constrictive Bronchiolitis: A Modified Delphi Study. Chest 2023; 163:599.</a></li><li><a class="nounderline abstract_t">Garshick E, Abraham JH, Baird CP, et al. Respiratory Health after Military Service in Southwest Asia and Afghanistan. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc 2019; 16:e1.</a></li><li><a class="nounderline abstract_t">King MS, Eisenberg R, Newman JH, et al. Constrictive bronchiolitis in soldiers returning from Iraq and Afghanistan. N Engl J Med 2011; 365:222.</a></li><li><a class="nounderline abstract_t">Stellman JM, Stellman SD, Christian R, et al. The extent and patterns of usage of Agent Orange and other herbicides in Vietnam. Nature 2003; 422:681.</a></li><li><a class="nounderline abstract_t">Schecter A, Needham L, Pavuk M, et al. Agent Orange exposure, Vietnam war veterans, and the risk of prostate cancer. Cancer 2009; 115:3369.</a></li><li><a class="nounderline abstract_t">Uzych L. Agent Orange, the Vietnam War, and lasting health effects. Environ Health Perspect 1991; 95:211.</a></li><li><a class="nounderline abstract_t">Kroenke K, Koslowe P, Roy M. Symptoms in 18,495 Persian Gulf War veterans. Latency of onset and lack of association with self-reported exposures. J Occup Environ Med 1998; 40:520.</a></li><li><a class="nounderline abstract_t">Roy MJ, Kraus PL, Seegers CA, et al. Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety. Mayo Clin Proc 2006; 81:1303.</a></li><li><a class="nounderline abstract_t">Schmidt CW. Soldiers and oil well smoke. Respiratory connection remains hazy. Environ Health Perspect 2002; 110:A690.</a></li><li><a class="nounderline abstract_t">Gronseth GS. Gulf war syndrome: a toxic exposure? A systematic review. Neurol Clin 2005; 23:523.</a></li><li class="breakAll">Chronic multisymptom illness in Gulf War veterans: Case definitions reexamined. The National Academies of Sciences, Engineering, and Medicine. 2014. Available at: https://www.nap.edu/catalog/18623/chronic-multisymptom-illness-in-gulf-war-veterans-case-definitions-reexamined (Accessed on June 01, 2021).</li><li><a class="nounderline abstract_t">Ismail K. A review of the evidence for a "Gulf War syndrome". Occup Environ Med 2001; 58:754.</a></li><li><a class="nounderline abstract_t">Fukuda K, Nisenbaum R, Stewart G, et al. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA 1998; 280:981.</a></li><li><a class="nounderline abstract_t">Steele L. Prevalence and patterns of Gulf War illness in Kansas veterans: association of symptoms with characteristics of person, place, and time of military service. Am J Epidemiol 2000; 152:992.</a></li><li><a class="nounderline abstract_t">Robbins PJ, Cherniack MG. Review of the biodistribution and toxicity of the insect repellent N,N-diethyl-m-toluamide (DEET). J Toxicol Environ Health 1986; 18:503.</a></li><li><a class="nounderline abstract_t">Franz TJ, Lehman PA, Franz SF, Guin JD. Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol 1996; 132:901.</a></li><li><a class="nounderline abstract_t">Haley RW, Kurt TL. Self-reported exposure to neurotoxic chemical combinations in the Gulf War. A cross-sectional epidemiologic study. JAMA 1997; 277:231.</a></li><li><a class="nounderline abstract_t">Roy MJ, Kraus PL, Seegers CA, et al. Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety. Mayo Clin Proc 2006; 81:1303.</a></li><li class="breakAll">Tables 522 and 524. In: Statistical Abstract of the United States: 2012. Available at: https://www.census.gov/prod/2011pubs/12statab/defense.pdf (Accessed on June 01, 2021).</li><li class="breakAll">Medical Services. Standards of Medical Fitness. AR 40-501, US Department of the Army, Washington, DC 2019.</li><li class="breakAll">US Department of Veterans Affairs. 38 CFR Book C, Schedule for Rating Disabilities. Available at: https://www.benefits.va.gov/warms/bookc.asp (Accessed on June 01, 2021).</li><li><a class="nounderline abstract_t">Finley EP, Zeber JE, Pugh MJ, et al. Postdeployment health care for returning OEF/OIF military personnel and their social networks: a qualitative approach. Mil Med 2010; 175:953.</a></li><li><a class="nounderline abstract_t">Lester P, Aralis H, Sinclair M, et al. The Impact of Deployment on Parental, Family and Child Adjustment in Military Families. Child Psychiatry Hum Dev 2016; 47:938.</a></li><li><a class="nounderline abstract_t">Flake EM, Davis BE, Johnson PL, Middleton LS. The psychosocial effects of deployment on military children. J Dev Behav Pediatr 2009; 30:271.</a></li><li><a class="nounderline abstract_t">Walker S. Assessing the mental health consequences of military combat in Iraq and Afghanistan: a literature review. J Psychiatr Ment Health Nurs 2010; 17:790.</a></li><li><a class="nounderline abstract_t">Sayer NA, Noorbaloochi S, Frazier P, et al. Reintegration problems and treatment interests among Iraq and Afghanistan combat veterans receiving VA medical care. Psychiatr Serv 2010; 61:589.</a></li></ol></div><div id="topicVersionRevision">Topic 15782 Version 77.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18376154" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Ventilator associated pneumonia in a military deployed setting: the impact of an aggressive infection control program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30786987" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Management and outcome of 597 wartime penetrating lower extremity arterial injuries from an international military cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26621637" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Retrospective Analysis of Long-Term Outcomes After Combat Injury: A Hidden Cost of War.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18816921" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : U.S. Army disease and nonbattle injury model, refined in Afghanistan and Iraq.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9847023" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Signs, symptoms, and ill-defined conditions in Persian Gulf War veterans: findings from the Comprehensive Clinical Evaluation Program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29889959" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Junctional Tourniquet Use During Combat Operations in Afghanistan: The Prehospital Trauma Registry Experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32209132" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Hemostatic agents for prehospital hemorrhage control: a narrative review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20531005" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Severe traumatic injury: regional variation in incidence and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20531005" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Severe traumatic injury: regional variation in incidence and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18176164" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Amputations in U.S. military personnel in the current conflicts in Afghanistan and Iraq.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18176164" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Amputations in U.S. military personnel in the current conflicts in Afghanistan and Iraq.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20803399" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Servicemembers and veterans with major traumatic limb loss from Vietnam war and OIF/OEF conflicts: survey methods, participants, and summary findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18234750" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Mild traumatic brain injury in U.S. Soldiers returning from Iraq.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21631321" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Detection of blast-related traumatic brain injury in U.S. military personnel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25335151" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Treatment of generalized war-related health concerns: placing TBI and PTSD in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31841649" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Distinguishing the Relative Impact of Post-Traumatic Stress Disorder and Traumatic Brain Injury on iPad-Measured Cognitive Function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22375973" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Placebo-controlled trial of amantadine for severe traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25643390" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Spinal injury hospitalizations among U.S. Army soldiers deployed to Iraq and Afghanistan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30037644" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Intraocular Foreign Body Trauma in Operation Iraqi Freedom and Operation Enduring Freedom: 2001 to 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17012689" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Posttraumatic stress disorder and depression in battle-injured soldiers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20530011" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Prevalence of mental health problems and functional impairment among active component and National Guard soldiers 3 and 12 months following combat in Iraq.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28215661" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Post-deployment screening for mental disorders and tailored advice about help-seeking in the UK military: a cluster randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15229303" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14670880" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Risk of suicide and related adverse outcomes after exposure to a suicide prevention programme in the US Air Force: cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30122274" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Suicide prevention in the military: a mechanistic perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19654382" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Association of cardiovascular risk factors with mental health diagnoses in Iraq and Afghanistan war veterans using VA health care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29555664" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Associations of Initial Injury Severity and Posttraumatic Stress Disorder Diagnoses With Long-Term Hypertension Risk After Combat Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19608954" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002-2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16507803" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Mental health problems, use of mental health services, and attrition from military service after returning from deployment to Iraq or Afghanistan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17728415" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Delayed-onset posttraumatic stress disorder: a systematic review of the evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17728415" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Delayed-onset posttraumatic stress disorder: a systematic review of the evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17728415" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Delayed-onset posttraumatic stress disorder: a systematic review of the evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25697603" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Depression in Gulf War veterans: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26892850" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Risk of depressive disorder following disasters and military deployment: systematic review with meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20435185" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Anxiety disorders increase risk for incident myocardial infarction in depressed and nondepressed Veterans Administration patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21208594" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Predictors of persistence of comorbid generalized anxiety disorder among veterans with major depressive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21208594" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Predictors of persistence of comorbid generalized anxiety disorder among veterans with major depressive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19819559" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Risk and protective factors associated with suicidal ideation in veterans of Operations Enduring Freedom and Iraqi Freedom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30423136" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Suicide in the Military: Understanding Rates and Risk Factors Across the United States' Armed Forces.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25390793" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Predicting suicides after psychiatric hospitalization in US Army soldiers: the Army Study To Assess Risk and rEsilience in Servicemembers (Army STARRS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23925620" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Risk factors associated with suicide in current and former US military personnel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25830941" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Risk of Suicide Among US Military Service Members Following Operation Enduring Freedom or Operation Iraqi Freedom Deployment and Separation From the US Military.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33369662" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Evaluation of Suicide Mortality Among Sexual Minority US Veterans From 2000 to 2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24590048" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Predictors of suicide and accident death in the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS): results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28472407" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Traumatic Brain Injury and Attempted Suicide Among Veterans of the Wars in Iraq and Afghanistan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25055175" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Sociodemographic and career history predictors of suicide mortality in the United States Army 2004-2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25012403" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Posttraumatic stress disorder and suicide in 5.9 million individuals receiving care in the veterans health administration health system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22301558" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Posttraumatic stress disorder, depression, and suicide in veterans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25677353" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Brief cognitive-behavioral therapy effects on post-treatment suicide attempts in a military sample: results of a randomized clinical trial with 2-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23925617" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Suicide, mental disorders, and the US military: time to focus on mental health service delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23561227" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Suicide risk assessment received prior to suicide death by Veterans Health Administration patients with a history of depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20968257" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Evaluating evidence of risk for suicide among veterans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20968257" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Evaluating evidence of risk for suicide among veterans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31450237" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20803405" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Quality of life for veterans and servicemembers with major traumatic limb loss from Vietnam and OIF/OEF conflicts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15497913" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Psychosocial adjustment to lower-limb amputation: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17188116" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Coping, affective distress, and psychosocial adjustment among people with traumatic upper limb amputations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12601647" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Depression after traumatic brain injury: a National Institute on Disability and Rehabilitation Research Model Systems multicenter investigation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14706943" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Major depression following traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16304488" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Evaluation of the Neurobehavioral Functioning Inventory as a depression screening tool after traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30901404" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Correlates of Depression in U.S. Military Service Members With a History of Mild Traumatic Brain Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18424429" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Understanding sequelae of injury mechanisms and mild traumatic brain injury incurred during the conflicts in Iraq and Afghanistan: persistent postconcussive symptoms and posttraumatic stress disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22648608" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Post deployment care for returning combat veterans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22228249" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Prevalence and costs of co-occurring traumatic brain injury with and without psychiatric disturbance and pain among Afghanistan and Iraq War Veteran V.A. users.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22228249" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Prevalence and costs of co-occurring traumatic brain injury with and without psychiatric disturbance and pain among Afghanistan and Iraq War Veteran V.A. users.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22228249" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Prevalence and costs of co-occurring traumatic brain injury with and without psychiatric disturbance and pain among Afghanistan and Iraq War Veteran V.A. users.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25466246" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Chronic multisymptom illness: a comparison of Iraq and Afghanistan deployers with veterans of the 1991 Gulf War.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29797218" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Chronic Multisymptom Illness Among Iraq/Afghanistan-Deployed US Veterans and Their Healthcare Utilization Within the Veterans Health Administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26519614" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Mindfulness-based Stress Reduction in Addition to Usual Care Is Associated with Improvements in Pain, Fatigue, and Cognitive Failures Among Veterans with Gulf War Illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25375071" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Arthritis among veterans - United States, 2011-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19318652" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Collaborative care for chronic pain in primary care: a cluster randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25751701" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Evaluation of Stepped Care for Chronic Pain (ESCAPE) in Veterans of the Iraq and Afghanistan Conflicts: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24930962" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Associations between prescription opioid use and sleep impairment among veterans with chronic pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25180008" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24931395" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24548466" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Persistent pain and comorbidity among Operation Enduring Freedom/Operation Iraqi Freedom/operation New Dawn veterans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22396516" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25038401" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Longitudinal interactions of pain and posttraumatic stress disorder symptoms in U.S. Military service members following blast exposure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20572470" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Substance use and mental health trends among U.S. military active duty personnel: key findings from the 2008 DoD Health Behavior Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17567397" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Substance use trends among active duty military personnel: findings from the United States Department of Defense Health Related Behavior Surveys, 1980-2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17485608" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21277712" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001-2010: Implications for screening, diagnosis and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29553778" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : The burden of co-occurring alcohol use disorder and PTSD in U.S. Military veterans: Comorbidities, functioning, and suicidality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Prevalence of substance use disorders among veterans and comparable nonveterans from the National Survey on Drug Use and Health</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20167440" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Recognition and management of alcohol misuse in OEF/OIF and other veterans in the VA: a cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15994714" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Improving the rates of quitting smoking for veterans with posttraumatic stress disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21139110" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20513680" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Screening for alcohol misuse and alcohol-related behaviors among combat veterans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20060237" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Relationship of combat experiences to alcohol misuse among U.S. soldiers returning from the Iraq war.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25841605" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Care of women veterans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30415636" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : The Prevalence of Military Sexual Trauma: A Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31713042" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Military Sexual Trauma in Older Women Veterans: Prevalence and Comorbidities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18252122" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Malaria reemergence in northern Afghanistan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17519407" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Malaria prevention measures in coalition troops in Afghanistan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16983619" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : In harm's way: infections in deployed American military forces.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17036599" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Bacteriology of war wounds at the time of injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17638186" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Infectious complications of open type III tibial fractures among combat casualties.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20299843" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Insights into acinetobacter war-wound infections, biofilms, and control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23042971" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Invasive mold infections following combat-related injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20175687" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21795879" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Multidrug-resistant bacterial colonization of combat-injured personnel at admission to medical centers after evacuation from Afghanistan and Iraq.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20500036" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21802175" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Longitudinal characterization of Acinetobacter baumannii-calcoaceticus complex, Klebsiella pneumoniae, and methicillin-resistant Staphylococcus aureus colonizing and infecting combat casualties.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15057192" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Update: Cutaneous leishmaniasis in U.S. military personnel--Southwest/Central Asia, 2002-2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17893312" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Visceral leishmaniasis: clinical observations in 4 US army soldiers deployed to Afghanistan or Iraq, 2002-2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18444807" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Outbreak of Q fever among US military in western Iraq, June-July 2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23535757" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17901434" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Anthrax vaccine and public health policy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17700077" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Smallpox vaccination: comparison of self-reported and electronic vaccine records in the millennium cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16333009" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Adverse events associated with smallpox vaccination in the United States, January-October 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18992783" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21704102" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Risk of disability for US army personnel vaccinated against anthrax, 1998-2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18376168" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Injury severity and causes of death from Operation Iraqi Freedom and Operation Enduring Freedom: 2003-2004 versus 2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9764699" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Epidemiology of immediate and early trauma deaths at an urban Level I trauma center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14698307" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Trauma fatalities: time and location of hospital deaths.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16832268" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Fresh whole blood transfusion: a controversial military practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20796254" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients (CME).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30189061" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Whole Blood Transfusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17828033" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17828033" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17828033" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25431117" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Formative evaluation of a multimedia self-administered computerized hearing loss prevention program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25431117" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Formative evaluation of a multimedia self-administered computerized hearing loss prevention program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25431117" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Formative evaluation of a multimedia self-administered computerized hearing loss prevention program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8054100" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : The effects of mustard gas, ionizing radiation, herbicides, trauma, and oil smoke on US military personnel: the results of veteran studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16043669" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Mortality in US Army Gulf War veterans exposed to 1991 Khamisiyah chemical munitions destruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20077228" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Mortality follow-up of veterans who participated in military chemical and biological warfare agent testing between 1962 and 1972.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17508257" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Human health risk assessment of explosives and heavy metals at a military gunnery range.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10942882" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : A fifty year mortality follow-up study of veterans exposed to low level chemical warfare agent, mustard gGas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33301016" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Long-term Health Outcomes Among Survivors Exposed to Sulfur Mustard in Iran.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33301016" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Long-term Health Outcomes Among Survivors Exposed to Sulfur Mustard in Iran.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36343686" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Consensus Statements on Deployment-Related Respiratory Disease, Inclusive of Constrictive Bronchiolitis: A Modified Delphi Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31368802" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Respiratory Health after Military Service in Southwest Asia and Afghanistan. An Official American Thoracic Society Workshop Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21774710" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Constrictive bronchiolitis in soldiers returning from Iraq and Afghanistan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12700752" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : The extent and patterns of usage of Agent Orange and other herbicides in Vietnam.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19415730" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Agent Orange exposure, Vietnam war veterans, and the risk of prostate cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1668234" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Agent Orange, the Vietnam War, and lasting health effects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9636932" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Symptoms in 18,495 Persian Gulf War veterans. Latency of onset and lack of association with self-reported exposures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17036555" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12440402" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Soldiers and oil well smoke. Respiratory connection remains hazy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15757795" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Gulf war syndrome: a toxic exposure? A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15757795" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Gulf war syndrome: a toxic exposure? A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11600733" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : A review of the evidence for a "Gulf War syndrome".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9749480" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Chronic multisymptom illness affecting Air Force veterans of the Gulf War.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11092441" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Prevalence and patterns of Gulf War illness in Kansas veterans: association of symptoms with characteristics of person, place, and time of military service.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3525852" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Review of the biodistribution and toxicity of the insect repellent N,N-diethyl-m-toluamide (DEET).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8712839" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Comparative percutaneous absorption of lindane and permethrin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9005273" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Self-reported exposure to neurotoxic chemical combinations in the Gulf War. A cross-sectional epidemiologic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17036555" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17036555" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17036555" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17036555" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21265301" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Postdeployment health care for returning OEF/OIF military personnel and their social networks: a qualitative approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26797704" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : The Impact of Deployment on Parental, Family and Child Adjustment in Military Families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19606059" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : The psychosocial effects of deployment on military children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21040224" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Assessing the mental health consequences of military combat in Iraq and Afghanistan: a literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20513682" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Reintegration problems and treatment interests among Iraq and Afghanistan combat veterans receiving VA medical care.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
